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Abstract 
Arginine and methionine are indispensable amino acids in neonates and have a 
metabolic role in creatine synthesis as well as protein synthesis. Arginine transfers its 
amidino group to glycine to form guanidinoacetic acid (GAA) which is then 
transmethylated to creatine. Methionine is the primary methyl donor for 
transmethylation reactions via S-adenosylmethionine (SAM).  SAM is demethylated 
to S-adenosylhomocysteine and transfers its methyl group to synthesize creatine, 
phosphatidylcholine (PC) and methylated DNA. In rapidly growing animals, the 
balance between requirements for growth versus those for maintenance becomes more 
critical as growth demands more amino acids for expansion of body protein mass as 
well as for the increased need for other critical metabolites. Therefore, our hypothesis 
is that dietary creatine and its precursor GAA can spare methionine and arginine. L-
[methyl-
3
H] methionine was infused to measure the sparing effect of dietary creatine 
and GAA and to quantify the partitioning of transmethylation reactions. The fractional 
synthetic rate of creatine, PC, DNA and protein were measured using isotope kinetics. 
Creatine supplementation increased the availability of methyl groups for other 
transmethylation reactions by reducing the labile methyl groups needed for creatine 
synthesis. GAA supplementation increased hepatic creatine levels 5-fold, but only 
when methionine was not limited. Excess dietary methionine enhanced PC synthesis 
by double but not hepatic protein synthesis. Sparing methionine with creatine or 
supplementing methionine did not increase hepatic protein synthesis, suggesting that 
hepatic protein synthesis is conserved in neonates when methionine is limiting. 
Therefore, creatine levels in neonatal piglets can be maintained only when the supply 
of methyl groups is expanded in the diet.   
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1. Introduction 
 Many amino acids play an important role in protein synthesis, as well as in 
other metabolic reactions. Indeed, a significant portion of the total amino acid pool 
ends up in non-protein roles. In particular, indispensable amino acids used in non-
protein roles must be carefully considered when establishing dietary requirements for 
these amino acids. Methionine is a sulfur-containing indispensable amino acid which 
is not only important for protein synthesis but also necessary for synthesis of cysteine, 
taurine, glutathione (Finkelstein, 1990), and also provides methyl groups for the 
synthesis of creatine, phosphatidylcholine and methylation of DNA (McBreairty et al., 
2013). Three-quarters of the creatine accretion in neonatal piglets is via de novo 
creatine synthesis (Brosnan et al., 2009). As a result, in growing piglets, there is a 
high demand for methionine for expansion of body protein and creatine synthesis. In 
addition, arginine is a conditionally essential amino acid in piglets that is necessary to 
maintain the urea cycle, as well as for the synthesis of creatine, nitric oxide and 
polyamines (Cynober et al., 1995). Arginine and methionine are involved in the 
process of creatine synthesis.  When more than one amino acid is involved in a 
synthetic pathway, up- or down-regulation of this pathway can spare amino acids for 
synthesis of protein or other metabolites. 
1.1. Creatine biosynthesis and regulation 
 Creatine biosynthesis is a simple two-step process.  In the kidney, arginine 
transfers its amidino group to glycine to synthesize guanidinoacetate (GAA) and 
ornithine via arginine:glycine amidinotransferase (AGAT) (Bloch & Schoenheimer, 
1941; Wyss & Kaddurah-Daouk, 2000). GAA is transferred to the liver, where SAM 
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gives its methyl group to GAA to synthesize creatine and SAH via GAMT (Cantoni & 
Vignos, 1954) (Figure 1.1). In neonatal piglets, a high activity of AGAT has been 
reported only in kidney and pancreas, whereas GAMT activity is high in liver and 
intermediate in the pancreas, suggesting most of creatine synthesis is by the renal 
hepatic axis; but the role of the pancreas in creatine synthesis remains unknown 
(Brosnan et al., 2009).   
 Creatine supplementation down-regulates AGAT activity as well as lowers the 
expression of mRNA of AGAT enzyme (McGuire et al., 1984), demonstrating that 
creatine synthesis is thought to be regulated via GAA production. On the other hand, 
GAMT activity is not regulated by creatine but it is competitively inhibited by SAH 
(Clarke & Banfield, 2001). 
1.1.1. Amino acids involved in creatine synthesis  
1.1.1.1. Methionine  
 In piglets, up to ~35% of the dietary methionine end up in creatine synthesis 
(Brosnan et al., 2009). The rate of transmethylation flux in 27 day old piglets is 33-40 
µmol.kg
-1
.h
-1 
(Riedijk et al., 2007) and the rate of creatine synthesis in growing piglets 
was estimated approximately 25 µmol.kg
-1
.h
-1
, suggesting that creatine synthesis may 
consumes 63-77% of the labile methyl groups used by piglets (Brosnan et al., 2009). 
Therefore, creatine synthesis can potentially be limited by methionine availability.     
a. Methionine requirement 
 Methionine is an essential amino acid important for protein synthesis, as well 
as for synthesis of taurine and cysteine and for supplying methyl groups to form 
methylated products. Therefore, it is important to estimate the methionine requirement 
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considering these many end products. Parenteral and enteral methionine requirements 
are 0.26 g/kg/d and 0.44 g/kg/d, respectively, in piglets and were estimated using the 
indicator phenylalanine oxidation technique (Shoveller et al., 2003b). The above 
requirements were estimated with no cysteine in the diet. The authors suggested that 
first-pass splanchnic metabolism consumes 30% of the dietary methionine in healthy, 
enterally-fed piglets, based on the difference in requirement relative to the route of 
feeding. Parenteral and enteral methionine requirements were also estimated using the 
above technique in the presence of excess cysteine.  Parenteral and enteral methionine 
requirements are 0.18 g/kg/d and 0.25 g/kg/d, respectively, with cysteine in the diet.  
b. Transmethylation 
 Methionine can be adenylated to form S-adenosylmethionine (SAM) via 
methionine adenosyltransferase (MAT) (Finkelstein, 1990). SAM is a universal 
methyl donor for more than a hundred transmethylation reactions (Brosnan and 
Brosnan, 2006). SAM transfers methyl groups to various substrates for the synthesis 
of transmethylated products and S-adenosylhomocysteine (SAH) via various 
methyltransferases. SAM level is regulated by glycine N-methyltransferase (GNMT) 
(Mato & Lu, 2007). SAM:SAH ratio can be used as a transmethylation index whereby 
a lower ratio suggests higher total transmethylation. SAH is an inhibitor of 
transmethylation reactions and is further hydrolyzed to homocysteine and adenosine 
via S-adenosylhomocysteine hydrolase (Hoffman et al., 1980). The most 
quantitatively important transmethylation pathways are phosphatidylcholine (PC) and 
creatine syntheses (see1.1) via phosphatidylethanolamine N-methyltransferase 
(PEMT) and guanidinoacetate methyltransferase (GAMT),   
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Figure 1.1: Methionine cycle and creatine synthesis (Source: MacKay et al., 2012 
and Stead et al., 2001) 
AGAT, L-arginine:glycine amidinotransferase; ATP, Adenosine triphosphate; BHMT, 
betaine:homocysteine methyltransferase; CBS, cystathionine β-synthase; CGL, 
cystathionine Ƴ-lyase; DMG, dimethylglycine; GAA, guanidinoacetate; GAMT, 
guanidinoacetate methyltransferase; Pi, inorganic phosphate; PPi, inorganic 
diphosphate; MAT, methionine adenosyltransferase; MS, methionine synthase, 
MTHFR, methylenetetrahydrofolate reductase; SAH, S-adenosylhomocysteine; 
SAHH, S-adenosylhomocysteine hydrolase; SAM, S-adenosylmethionine; SHMT, 
serine hydroxymethyltransferase; THF, tetrahydrofolate 
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respectively (Mudd et al., 2007; McBreairty et al., 2013). Less quantitatively 
important transmethylation reactions are sarcosine synthesis and DNA methylation via 
GNMT and DNA methyltransferase (DNMT), respectively (Mudd et al., 2007). 
 i. PC synthesis 
 Approximately 70% of PC synthesis occurs via the cytidine-diphosphate-
choline pathway, also known as the Kennedy pathway, which is not SAM dependent; 
the remaining 30% of PC is synthesized via the PEMT pathway (Reo et al., 2002). PC 
synthesis catalyzed by choline kinase, CTP:phosphocholine cytidylyltransferase and 
choline-phosphatetransferase to form PC from choline, where CTP:phosphocholine 
cytidylyltransferase is the rate-limiting enzyme (DeLong et al., 1999). SAM provides 
three methyl groups to phosphatidylethanolamine to produce PC via the PEMT 
pathway, which demonstrates the quantitative importance of methyl consumption for 
PC synthesis, compared to creatine synthesis which only consumes one methyl group 
(Stead et al., 2006). Plasma homocysteine was reduced by 50% in PEMT
-/- 
mice 
compared to wild type mice suggesting the PEMT pathway significantly contributes to 
homocysteine production in the liver (Stead et al., 2006).  There are two forms of 
PEMT enzyme that are specific to the liver: PEMT 1 is localized on the endoplasmic 
reticulum and methylates phosphatidylethanolamine (PE) to phosphatidyl-N-
monomethylethanolamine in the rate limiting step followed by two subsequent 
methylation reactions via PEMT 2, which is associated with mitochondria (Vance et 
al., 1997). The up-regulation of the PEMT pathway has been observed in piglets fed a 
choline-free diet with methionine restriction, suggesting PEMT flux is regulated by 
PC demand (Robinson et al., 2013). Moreover, a minimal effect on hepatic PC and PE 
has been observed in PEMT
-/-
 mice demonstrating the coordinated regulation of PC 
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synthesis (Walkey et al., 1998). A large amount of PC found in the liver is secreted as 
lipoproteins. In particular, PC is important for secretion of very low density 
lipoproteins (VLDL) (Vance et al., 2007).    
ii. DNA methylation 
 SAM transfers its methyl group to the 5' carbon on cytosine residues in the 
CpG site of DNA to form methylated DNA via DNMT enzyme. This modification 
leads to alteration of the expression of certain genes (Hermann et al., 2004). These 
epigenetic changes are tissue-specific and nutritionally influenced by dietary methyl 
donors such as methionine, choline and folate. For example, excess methionine 
induces changes in DNA methylation and expression of several genes (Waterland, 
2006). However, it has not been firmly established whether excess methionine induces 
hyper- or hypomethylation (Waterland, 2006). With multiple methyl donors, diets 
deficient in methionine, choline and folic acid (Wainfan et al., 1989), or choline 
(Locker et al., 1986; Tsujiuchi et al., 1999) led to hypomethylation as observed in rat 
liver. Moreover, DNA hypomethylation and patterns of the gene expression were 
restored by folate therapy in humans (Ingrosso et al., 2003). Although the relationship 
between dietary methyl donors and epigenetic modifications is not well described, it is 
rather consistent that these modifications are alterable by manipulating the diet. 
iii. N-methyl glycine (sarcosine) synthesis 
 SAM transfers a methyl group to glycine to form N-methyl glycine, also 
known as sarcosine, and SAH via glycine-N-methyl transferase enzyme (GNMT). 
This pathway is considered an overflow to maintain hepatic methionine, SAM and 
homocysteine at normal levels when methionine is excess (Mudd et al., 2007). In 
humans, absence of GNMT causes a rise in SAM and methionine, demonstrating the 
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lack of SAM utilization via GNMT and suggesting its importance in SAM 
homeostasis (Mudd et al., 2001). 
c. Remethylation and transsulfuration 
 SAH, a product of transmethylation, is hydrolyzed to homocysteine and 
adenosine via SAH hydrolase. The homocysteine can either remethylate to form 
methionine by BHMT or MS, convert to cysteine via transsulfuration, or be exported 
into blood (Brosnan et al., 2004). In neonatal piglets, it has been shown BHMT and 
MS activities are similar (i.e., 65.3 and 54.5 µmol.kg
-1
.h
-1
, respectively) in the liver 
(Brosnan et al., 2009). Also, Riedijk et al. estimated the rate of total remethylation is 
8-14 µmol.kg
-1
.h
-1
 in 27 day old piglets, suggesting piglets have sufficient capacity to 
refill the liver methionine pool (Riedijk et al., 2007).  
 Irreversible oxidation of homocysteine forms cystathionine via cystathionine-
β-synthase (CBS) using condensation of serine and vitamin B6 as a cofactor 
(Finkelstein, 1990). Cystathionine-γ-lyase further oxidizes cystathionine to form 
cysteine and α- ketoglutarate, also using vitamin B6 as a cofactor. Cysteine can be 
further metabolized to taurine and glutathione (Finkelstein, 1990).  CBS is the rate-
limiting enzyme for transsulfuration and its activity is limited to liver, kidney, 
intestine and pancreas (Bauchart-Thevret et al., 2009) and is allosterically activated by 
SAM (Prudova et al., 2006).  
1.1.1.2. Arginine  
 Arginine is a conditionally essential amino acid in neonatal piglets, and plays 
an important role in protein synthesis and other metabolic pathways such as synthesis 
of creatine, nitric oxide and polyamines. Furthermore, arginine plays an important role 
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in ammonia detoxification via the urea cycle. In the liver, arginine is broken down into 
urea and ornithine by arginase. Ammonia and bicarbonate are converted into 
carbamoyl phosphate by carbamoyl phosphate synthetase-1 (CPS-1), which is the 
substrate for ornithine transcarbamoylase (OTC). Jones demonstrated that conversion 
of glutamate to L-pyrroline-5-carboxylate (P5C) is limited to the small intestine and 
thymus because P5C synthase is found exclusively in these tissues (Jones, 1985). The 
liver is the primary site for urea synthesis due to very high arginase activity. The 
kidney is the primary site for arginine synthesis from citrulline and is also involved in 
ammonia removal via the glutamine nitrogen shuttle (Bertolo & Burrin, 2008). Excess 
dietary arginine down-regulates CPS-1 and OTC, but low arginine in the diet up-
regulates CPS-1 and OTC to maintain citrulline synthesis thereby maintaining 
arginine metabolism in the kidney (Bertolo & Burrin, 2008).  
 In piglets, up to ~20% of the arginine end up in creatine synthesis (Brosnan et 
al., 2009). In one week old pigs, sow's milk provides ≤ 40% of arginine requirements. 
In sow-fed piglets, approximately 17-20% of milk arginine may be used for creatine 
synthesis (Wu et al., 2004). In piglets, endogenous arginine synthesis is inadequate to 
meet their requirement when fed arginine free diet (Brunton et al., 1999). Therefore, 
creatine synthesis can potentially be limited arginine availability. 
a. Arginine de novo synthesis in adults 
 Glutamate, glutamine and proline are the dietary precursors for arginine 
synthesis in adults (Van De Poll et al., 2007). In de novo synthesis of arginine, 
glutamate and proline are converted to P5C by P5C synthase and proline oxidase, 
respectively. P5C is converted to either proline by P5C reductase or ornithine by 
ornithine aminotransferase (Brunton et al., 1999).  In the gut, low argininosuccinate 
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synthase (ASS) and argininosuccinate lyase (ASL) activities and higher arginase 
activity lead to net synthesis of citrulline and export into the portal vein (Cynober, 
2002). In the kidney, higher ASS and ASL activities with low renal arginase lead to 
net arginine synthesis and export into circulation (Bertolo & Burrin, 2008).  
Therefore, de novo arginine synthesis in adults occurs through this small intestine-
renal axis (Ligthart-Melis et al., 2008).   
 
Figure 1.2: Amino acids involved in arginine metabolism (Source: Bertolo and 
Burrin, 2008) 
ASL, argininosuccinate lyase; ASS, argininosuccinate synthetase; CPS-1,carbamoyl 
phosphate synthetase; OAT, ornithine aminotransferase; OTC, ornithine 
transcarbamoylase; P5C, pyrroline-5-carboxylate; P5CDH, pyrroline-5-carboxylate 
dehydrogenase 
 
  
10 
 
b. Arginine de novo synthesis in neonates 
 In contrast to adult rats, de novo arginine synthesis does not follow the 
intestinal-renal axis in neonates. Several studies in neonatal piglets have demonstrated 
that arginine is synthesized in and released by the small intestine (Brunton et al., 
1999; Bertolo et al., 2003b; Wilkinson et al., 2004). Bertolo et al. demonstrated that 
50% of the arginine requirement is synthesized in the neonatal intestine suggesting 
that a significant fraction of the requirement should enter from the diet (Bertolo et al., 
2003a). Wu and co-workers demonstrated that sow's milk is deficient in arginine and 
only ~40% of the arginine requirement is derived from sow's milk in 1 week old 
piglets. Therefore, they suggested that piglets need to synthesize substantial arginine 
to compensate for deficient arginine in sow's milk (Wu et al., 2004). In neonatal 
piglets, feeding arginine-free diets via the intravenous (IV) route leads to onset of 
severe hyperammonemia, regardless of proline levels in the diet (Brunton et al., 
1999). The same diet when delivered via the gastric route led to development of 
moderate hyperammonemia after 8 h of feeding, which suggests that de novo arginine 
synthesis from proline only takes place when diet is delivered into the gut. Proline is 
the only precursor for arginine synthesis in neonates due to lack of P5C synthase 
activity in the neonatal intestine (Brunton et al., 1999).  
c. Arginine requirement  
 Based on the National Research Council (NRC) recommendation, which is an 
extrpolation from older pigs, the dietary requirement of arginine is estimated at 0.38 
g/kg/d for neonatal piglets (National Research Council, 1988). Suckling piglets gain 
arginine (0.47 g/kg/d) via sow milk (Moughan et al., 1991) which contains more than 
the requirement recommended by NRC. However, there is question as to whether the 
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NRC requirement is adequate given data by Wu and co-workers (Wu et al., 2004). 
Brunton et al. demonstrated that >1.2 g arginine/kg/d is necessary to maximize muscle 
protein synthesis in enterally fed piglets (Brunton et al., 2003), demonstrating that the 
NRC requirement is likely underestimated. 
1.1.1.3. Glycine 
Brosnan et al. (2009) also estimated that up to 12% of dietary glycine ends up in 
creatine synthesis compared to 2.7% of the net glycine used for protein synthesis in 
the body. However, pigs can synthesize a considerable amount of glycine (Wang et 
al., 2013) and glycine is also readily available from protein. Therefore, creatine 
synthesis would not likely place a metabolic burden on the availability of glycine as it 
does for arginine and methionine. 
1.2. Creatine transport and excretion 
 The resulting creatine is exported from liver and transported into high energy 
demand tissues via the sodium dependent creatine transporter (Fitch & Shields, 1966). 
Creatine is reversibly phosphorylated to phosphocreatine via creatine kinase enzyme. 
The larger pools of creatine and phosphocreatine are stored in high energy demand 
tissues such as skeletal muscle, cardiac muscle and brain tissue (Wyss & Kaddurah-
Daouk, 2000). During high energy demands, phosphocreatine acts as an energy buffer 
by synthesizing ATP (Wallimann et al., 1992).   
 About 1.7% of the total creatine pool is irreversibly and spontaneously 
converted into creatinine each day which is excreted via urine in humans (Brosnan et 
al., 2009). Therefore, there is a need for continual replacement of this creatine lost as 
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creatinine. Creatine can accrue in the body both by de novo synthesis and from dietary 
sources rich in creatine such as red meat and fish (Wyss & Kaddurah-Daouk, 2000).  
  1.3. Sources of creatine in neonates 
 In neonatal piglets, ~25% of creatine accretion comes from sow milk and the 
rest is synthesized endogenously. A previous study in neonatal piglets reported that 
creatine synthesis may consume two thirds of the labile methyl groups, demonstrating 
the high demand for creatine during early development (Brosnan et al., 2009). Edison 
and colleagues (2013) have shown that breast-fed infants and infants receiving cow 
milk-based formula receive 9% and 36% of their creatine needs from their respective 
diets. In contrast, a soy-based formula has been shown to have a negligible amount of 
creatine (Edison et al., 2013). Therefore, the entire creatine requirement needs to be 
synthesized endogenously in infants receiving soy-based formulas. The variability in 
dietary creatine intake potentially leads to a considerable metabolic burden on the 
precursor amino acids for creatine synthesis.  
1.4. Applications of creatine 
1.4.1. Feed additives 
 Creatine is commonly used as a feed additive in the poultry industry to 
increase muscle creatine and growth rate. Several studies showed that adding creatine 
to arginine deficient diets elicits a growth response in chicks (Fisher et al., 1956; 
Austic & Nesheim, 1972). Creatine supplementation has also been shown to increase 
the weight gain in finishing pigs (Maddock et al., 2002; Young et al., 2005).  It has 
been suggested that creatine monohydrate increases the water holding capacity 
(WHC) of pork (Berg & Allee, 2001; Young et al., 2005). Thus, it remains unknown 
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whether increased weight gain from creatine supplementation is due to WHC. It has 
also been shown that creatine supplementation decreases plasma homocysteine in rats 
(Stead et al., 2001; Deminice et al., 2009) and in humans (Korzun, 2003) suggesting a 
lower production of GAA. Although in contrast, Steenge and colleagues have reported 
no effect of creatine supplementation on levels of plasma homocysteine in humans 
(Steenge et al., 2001). Creatine synthesis has been shown to be proportional to GAA 
availability in rats (Da Silva et al., 2009) and in piglets (McBreairty et al., 2013). 
Moreover, in humans, a single dose of GAA ingestion has been shown to increase 
plasma GAA, creatine and homocysteine (Ostojic et al., 2014). In piglets, portal vein 
infusion of GAA increases methyl incorporation to creatine. This methyl 
incorporation into creatine leads to lower methyl incorporation into PC as well as 
lower methionine incorporation into protein (McBreairty et al., 2013), suggesting 
GAA increases the methyl demand and limits methyl and methionine availability. 
Therefore, further studies are required to assess the effective use of creatine as feed 
additives.  
1.4.2. Sport nutraceutical 
 Creatine supplementation has been shown to increase total muscle creatine in 
humans (Harris et al., 1992). Further, Harris et al. demonstrated that supplementation 
of creatine increases the total creatine in exercised legs more so than in control legs. 
Creatine accretion is also higher when creatine is supplemented with a high 
carbohydrate diet (Green et al., 1996).  In other studies, it has been demonstrated that 
ingestion of creatine at a rate of 20 g/day for six days rapidly increases the creatine 
content of skeletal muscle and this accrued creatine can be maintained by 
supplementing creatine at a rate of 2 g/day (Hultman et al., 1996). An alternative 
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regime is supplementing creatine at a dose of 3 g/day for 4 weeks which leads to a 
creatine load in skeletal muscle similar to the load of supplementing creatine at a dose 
of 20 g/day for six days (Hultman et al., 1996). Therefore, creatine supplementation is 
effective in athletics by enhancing the creatine content of muscle and accommodating 
the high energy demand during exercise. 
1.5. Amino acids sparing 
 In the animal feed industry, a major component of the total feed costs are 
amino acids and protein. As a result, synthetic amino acids are used to replace protein 
ingredients to minimize the feed cost. Moreover, most of the amino acids in the diet 
could be partially spared by a precursor or related metabolite. For example, creatine 
and GAA can spare methionine and arginine for protein synthesis and growth. 
Hegsted et al. suggested many years ago that creatine can spare arginine and glycine 
in poultry (Hegsted et al., 1941). Several other studies have shown that adding 
creatine to casein-based diets improved growth rate in chicks, since casein was 
observed to be lacking in arginine (Fisher et al., 1956; Austic & Nesheim, 1972). 
 GAA or creatine supplementations have been shown to increase weight gain 
and muscle creatine in poultry suggesting GAA can replace creatine (Almquist et al., 
1941). Further, Almquist et al. first mentioned in 1941 that GAA can spare arginine 
and glycine in the same manner that creatine could in poultry. In growing piglets, 
creatine supplementation did not seem to induce growth, whether added to the diet 
(Miller et al., 1962; Guzik et al., 2000) or injected intraperitoneally (Baker et al., 
1961). Also, Baker et al. and Miller et al. reported that creatine supplementation did 
not increase muscle creatine (Baker et al., 1961; Miller et al., 1962). It is important 
that dietary arginine and methionine should be marginal in order to observe sparing 
15 
 
effects of these amino acids. In growing-finishing pigs, large doses of creatine 
monohydrate (25 g/d) for a short period (10 days) did not influence growth 
performance (O'Quinn et al., 2000).  
 Recently it was shown that GAA can spare arginine in poultry (Ringel et al., 
2008). Further studies showed that GAA can only spare arginine when arginine is 
deficient in diets in broiler chicks (Dilger et al., 2013). McBreairty et al. were the first 
to demonstrate in neonatal piglets that acute portal infusion of GAA resulted in an 80-
120% increase in methyl incorporation into creatine with a concomitant decrease by 
75–85% and 40% in methyl incorporation into PC and protein, respectively, 
suggesting methyl groups were limited for PC and protein synthesis (McBreairty et 
al., 2013). With respect to methionine, it has been shown that cysteine can spare 
methionine in animals and humans. Shoveller et al. estimated that ~40% of the 
methionine requirement can be spared by excess cysteine in growing piglets 
(Shoveller et al., 2003a). Moreover, folate and betaine can spare methionine 
(Fukagawa, 2006) and betaine has been shown to spare methionine in chickens 
(Dilger et al., 2007) but not in finishing pigs (Matthews et al., 2001). Supplementing 
creatine with or without glycine has been shown not to have an effect on the growth 
response suggesting that creatine does not spare glycine for growth in chicks 
(Waterhouse & Scott, 1961).  
1.6. Tissue protein synthesis in neonatal piglets 
 Protein synthesis and breakdown are together called protein turnover (Yin et 
al., 2013). In rapidly growing animals, there is a high demand for amino acids for 
growth and other metabolic pathways. Of note, methionine and arginine are essential 
amino acids in piglets and both are involved in protein synthesis as well as in creatine 
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synthesis (Brosnan et al., 2009). In piglets, 75% of the creatine must be synthesized 
via de novo synthesis (Brosnan et al., 2009). Therefore in rapidly growing animals the 
requirement of these amino acids is high as the body protein mass expands. Liver and 
gut fractional protein synthesis is much higher than in other tissues and organs and 
together both of these tissues account for 25% of the whole-body protein synthesis 
(Stoll et al., 1998). Bauchart-Thevret and coworkers demonstrated that the fractional 
synthetic rate of hepatic protein synthesis was reduced in piglets receiving sulfur 
amino acids free diets, as determined using an (
15
N)-cysteine tracer method (Bauchart-
Thevret et al., 2009). Recently, Robinson et al. demonstrated that methyl and 
methionine deficient diets led to ~70% reduction in fractional protein synthesis in 
muscle, suggesting that methionine can be re-synthesized via the remethylation 
pathway when methyl donors are available (Robinson et al., 2014). It has also been 
demonstrated that adding arginine to milk-replacement diets (deficient in arginine) 
increased the growth rate in piglets (Kim et al., 2004). Enteral arginine 
supplementation increases the hepatic protein synthesis compared to parenteral 
arginine supply as demonstrated using [
3
H] phenylalanine isotope infusion technique 
in piglets (Dinesh et al., 2013). Therefore, tissue protein synthesis in piglets is 
sensitive to methionine and arginine intakes.  
1.7. Piglets as a model for infants 
 The pig is an excellent model to examine questions related to amino acid 
metabolism (Miller & Ullrey, 1987). The piglet's digestive anatomy and physiology 
and amino acid metabolism resemble that of humans during early development. 
Moreover, the miniature piglet’s small size is beneficial for biomedical research 
(Miller & Ullrey, 1987). Studies of amino acid metabolism and requirements are well 
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established in piglets, and these requirements are proportionately very similar to 
human requirements. Indeed, Chapman et al. demonstrated that piglet amino acid 
requirement data are transferrable to the human infant when adjustments are made for 
rapid growth of the piglets (Chapman et al., 2009).  In particular, the methionine 
requirement has been studied in enterally fed and parenterally fed neonatal piglets 
with or without excess levels of cysteine (Shoveller et al., 2003a; Shoveller et al., 
2003b). Similarly, the arginine requirement has been estimated in neonatal piglets in 
terms of muscle protein synthesis as a functional determinant of adequate arginine 
(Brunton et al., 2003). Therefore, piglets are a clinically relevant model to study 
amino acid metabolism as it relates to human infants.  
1.8. Rationale, hypothesis and objectives 
 Creatine synthesis requires glycine, arginine and methionine. It has been 
postulated that creatine can spare arginine and glycine for growth (Hegsted et al., 
1941). However, creatine synthesis likely does not present a burden on glycine in pigs 
as glycine is rapidly synthesized. In contrast, Wietlake et al. proposed that creatine 
and arginine are interchangeable in poultry since arginine is essential. Even though 
creatine can spare arginine, this only occurs when arginine is limiting; no 
improvement has been demonstrated when creatine is supplemented to an arginine 
adequate diet (Wietlake et al., 1954). In studies in pigs, creatine supplementation did 
not induce growth in weanling or growing-finishing pigs (O'Quinn et al 2000). 
However, this may be due to arginine and methionine not being marginal in the diet so 
the sparing effect on these amino acids would not be expected. Indeed, Robinson et al. 
has demonstrated that creatine synthesis is more sensitive to methyl and methionine in 
the diet when their supply is limited (Robinson et al., 2013). Overall, creatine 
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synthesis potentially consumes approximately 35% of dietary methionine and 20% of 
dietary arginine in suckling neonatal piglets (Brosnan et al., 2009). However, this 
consumption is an upper estimate as methionine and arginine can be re-synthesized 
via remethylation and the urea cycle, respectively, in the liver. Therefore, evaluating 
the burden of creatine synthesis on methionine and arginine metabolism is more 
complex. 
 Creatine synthesis is proportional to GAA availability. Almquist et al. first 
mentioned that GAA can spare arginine and glycine, similar to creatine, when it was 
demonstrated that the creatine load in muscle can be achieved either by creatine or 
GAA supplementation (Almquist et al., 1941). GAA can spare arginine for growth 
when GAA is supplemented to an arginine deficient diet which has been demonstrated 
in broiler chicks (Dilger et al., 2013). In piglets, arginine may also limit growth due to 
limiting arginine in sow milk (Wu et al., 2004). Therefore, supplementation of GAA 
could also be beneficial in suckling piglets when piglets are incapable of synthesizing 
sufficient amount of arginine for growth.  
 We hypothesized that dietary creatine can spare arginine and methionine for 
protein synthesis and growth in piglets, and that dietary GAA could similarly spare 
arginine.  
Objectives 
01. To quantify the amino acid sparing effects of dietary creatine and GAA for protein 
synthesis and growth when arginine and methionine are marginally deficient in diet. 
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02. To quantify the partitioning of methionine-derived methyl groups into the 
quantitatively important transmethylation reactions in response to dietary creatine and 
GAA supplementation when arginine and methionine are deficient or excess in diet. 
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2. Materials and methods 
2.1. Animals and surgical procedures 
 Our hypothesis was tested in a Yucatan miniature pig model. All animal 
procedures were reviewed and approved by the Institutional Animal Care Committee 
at Memorial University of Newfoundland and conformed to the guidelines of the 
Canadian Council on Animal Care. Thirty four, 7-10 day-old Yucatan miniature 
piglets were obtained from a breeding colony at Memorial University of 
Newfoundland, St. John's, NL, Canada. A sample size of six per group was calculated 
with significance level of 0.05 and power of 0.80 to detect a 10% difference using 
previous variance estimates from data for transmethylation partitioning in piglets; 
however, I used a sample size of seven, except for the Base+GAA group (n=6). The 
study planned to block by litter and use five animals from each litter for each of the 
five treatments; however, this goal could not be achieved in one set of piglets because 
of an unexpected mortality.  
 Piglets were transported from the breeding colony via Animal Care Services 
staff to the Biotechnology building, Memorial University of Newfoundland just before 
the surgery. Upon arrival, piglets were weighed and anaesthetized with an 
intramuscular injection of ketamine hydrochloride (Bimeda Canada, Cambridge, ON, 
Canada) and acepromazine (Vetoquinol, Quebec, Canada) at doses of 22 mg/kg and 
0.5 mg/kg, respectively. Piglets were then given an atropine sulfate (Rafter and 
Products, Canada) injection of 0.05 mg/kg via subcutaneous route to reduce air-way 
secretions. Afterwards, piglets were intubated and anaesthesia was maintained with 
1.5% isoflurane (Abbott Laboratories Inc., Canada) mixed with oxygen (1.5 l/min). 
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The animal was cleaned with soap and Proviodine prior to the surgery. Just before 
surgery, piglets were also given a dose of buprenorphine analgesic (Temgesic, Reckitt 
Benckiser Healthcare, UK) providing 0.03 mg/kg intramuscularly; analgesic was 
repeated every 12 h for 2 days. In each piglet, two venous catheters and a gastric 
catheter were surgically implanted. One silastic catheter was introduced into the left 
external jugular vein and advanced to the cranial vena cava immediately cranial to the 
heart. The other catheter was introduced into the left femoral vein and advanced to the 
caudal vena cava immediately caudal to the heart. The jugular catheter was used for 
diet infusion during the initial 2 days of the study period, and the femoral catheter was 
used to collect blood samples throughout the protocol. A mid ventral incision was 
made to open the abdominal cavity for implantation of a gastric catheter (Rombeau & 
Caldwell, 1984). The body temperature, respiratory rate, heart rate and oxygen 
saturation were monitored throughout the surgical procedure.  
 Immediately following surgery, piglets were transferred to the animal housing 
room, with a 12-h light and 12-h dark cycle where the temperature was maintained at 
28 °C with supplemental heating lamps. Piglets were housed individually in metabolic 
cages which allowed visual and aural contact with other piglets. The IV and 
intragastric (IG) lines were connected via a dual-port swivel and tether system (Lomir 
Biomedical, Montreal, Quebec, Canada) to facilitate continuous IG diet infusion and 
to allow the piglets to move freely around the cage. Piglets received an IV injection of 
0.5 ml of the anti-bacterial Borgal (Trimethoprim 40 mg/ml and sulfadoxine 200 
mg/ml; Intervet Canada Ltd, Canada) which was diluted to 10 ml with saline. Anti-
bacterial veterinary ointment was applied on the incision sites until they healed.  
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2.2. Experimental design and diet 
 Complete elemental diets (Appendix I) was prepared in the laboratory using 
crystalline L-amino acids (Evonik Industries AG, Hanau-Wolfgang, Germany or 
Sigma, St. Louis, MO, USA). The amino acid profile was based on a commercially 
available parenteral nutrition solution for infants (Vaminolact; Fresenius Kabi, 
Germany) with slight modifications for piglets (Wykes et al., 1993). Dry amino acids 
were thoroughly mixed together and then dissolved in water at 55-65 °C under a cover 
of nitrogen gas to protect from oxidation. D-glucose and major minerals (Appendix II) 
were added and the solution was brought up to the desired volume using pyrogen-free 
water. The diets were sterilized by filtering through a 0.22 µm filter (ACROPAK, Pall 
Corporation, Switzerland) into sterile IV bags (Baxter Corporation, Mississauga, ON, 
Canada) in a laminar flow hood and kept refrigerated and protected from light until 
needed. Similar to the above procedure, five experimental diets (Appendix I) were 
prepared to test our hypothesis. Alanine and aspartate were adjusted to make the diets 
isonitrogenous. 
2.2.1. Diet groups 
Base diet (Base): Base diet was designed to marginally control transmethylation 
reactions and protein synthesis. In this diet, methionine was added to provide 0.2 
g/kg/day; this represents 80% of the methionine requirement determined by Shoveller 
et al. with excess cysteine (Shoveller et al., 2003b). Arginine was fed at 0.3 g/kg/day, 
which corresponded to 79% of NRC requirement (i.e., 0.38 g/kg/day); this chosen 
intake also corresponded to 50% of the intake value at the breakpoint in the plasma 
arginine concentration when piglets were fed increasing levels of arginine (Brunton et 
al., 2003). These marginal levels of methionine and arginine allowed us to detect both 
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decreases and increases in amino acid utilization due to supplement treatments. In 
other words, if a supplement spared methionine for protein synthesis, this increase in 
protein synthesis can only be detected if methionine was limiting in the first place. 
Base diet with GAA (Base+GAA): The purpose of this diet was to determine 
whether or not GAA can spare arginine. Base diet was supplemented with GAA at a 
rate of 0.09 g/kg/day. This amount of GAA, if entirely converted into creatine, would 
fulfill the total creatine accretion rate of the piglet at this age (Brosnan et al., 2009). 
Base diet with creatine (Base+CRE): The purpose of this diet was to determine 
whether or not creatine can spare arginine and methionine for protein synthesis. Base 
diet was supplemented with creatine (as creatine monohydrate) at a rate of 0.12 g 
creatine/kg/day, which is equal to the total creatine accretion rate of the piglet 
(Brosnan et al., 2009). 
Excess arginine and methionine diet (Excess Arg/Met): Excess dietary arginine 
(1.8 g/kg/day) and methionine (0.5 g/kg/day) levels were chosen so each are in excess 
of the respective whole body requirements (i.e., at least twice the estimated 
requirements).  
GAA with Excess methionine (GAA/Excess Met): The purpose of this diet was to 
determine if methionine can limit creatine synthesis from supplemented GAA. If 
methionine is limited in the Base+GAA diet, then utilization of GAA (ie conversion to 
creatine) might be limited by marginal methionine. So this group was supplemented 
with GAA plus excess methionine to ensure GAA is methylated to creatine.  
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2.2.2. Trace element mixture 
 All trace elements were dissolved in pyrogen-free water and filtered through a 
0.22 µm syringe filter (Millipore Ireland Ltd., Ireland) into a sterile intravenous bag 
and kept in a refrigerator and protected from light until needed (Appendix III). 
2.2.3. Vitamin mixture 
 The vitamin mixture was calculated based on the Multi-12/K1 pediatric 
multivitamin commercial solution dose. All water soluble vitamins and the water 
soluble form of vitamin K were prepared separately and neutralized with sodium 
citrate (Appendix IV). The solutions were filtered through a 0.22 µm syringe filter 
into a sterile intravenous bag and kept in refrigerator and protected from light until 
needed. Fat soluble vitamins A, D and E were mixed in vegetable oil and stored in a 
sterile bottle under refrigeration and protected from light until needed. 
 Three ml of Multi-12/K1 pediatric vitamins, 1 ml of iron dextran (Ventoquinol 
Canada Inc., Canada) that provides 2 mg of iron per kg of body weight, 3 ml of trace 
element mix and 145 ml of 20% Intralipid (Fresenius Kabi, Uppsala, Sweden) were 
mixed with 750 ml of diet just before feeding. Commercially available multivitamins 
(Multi-12/K1 Pediatric multivitamins, Baxter, Canada) were used during the 
adaptation period (which included IV feeding) and then laboratory-made 
multivitamins were used to mix with the experimental diets. Fat soluble vitamins were 
directly injected into the stomach via the gastric catheter. The complete diet provided 
15 g amino acids/kg/day and 1.1 MJ of metabolizable energy/kg/day with lipids 
supplying 50% of non-protein energy. Vitamins were provided at more than 100% and 
trace minerals were provided at a maximum of 200% of requirements (National 
Research Council, 1998).  
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On the day of surgery, complete elemental diet (adaptation diet) was continuously 
infused IV at 50% of the maximal rate (13.5 ml/kg/h) by dual channel infusion pumps 
(Baxter Healthcare Corporation, Deerfield, USA). On the morning of the following 
day, 50% of diet was infused IV and 50% was infused via the gastric catheter; IG 
infusion was increased to 75% and IV infusion was reduced to 25% of the maximal 
rate that evening. By the next morning, 100% of diet was infused IG. After 2 days of 
adaptation to the complete elemental diet, piglets were switched to one of the above 
test diets which was infused via the gastric catheter at 13.5 ml/kg/h for 5 days. During 
this period, the body weight of each animal was measured every day in the morning 
and the diet infusion rate was adjusted to the body weight.  
2.3. Isotope infusion protocol and necropsy procedure 
 On study day 7, all piglets received a primed dose of 30 µCi/kg L-[methyl-
3
H] 
methionine (30-80 Ci/mmol; American Radiolabeled Chemicals) infused via the 
gastric catheter. At the same time a constant infusion of 30 µCi/kg/h of L-[methyl-
3
H] 
methionine was initiated and continued for 6 h.  The constant infusion was provided 
as half of the hourly dose infused intragastrically every 30 min (Figure 2.1). During 
the infusion, 1 ml of blood was obtained from the femoral catheter at baseline and 
every 30 min. The blood samples were immediately transferred to a heparinized 
vacutainer and centrifuged at 1300g (VWR Clinical 200, Hermle Labortechnik, 
Wehingen, Germany) for 5 min to separate plasma. Plasma samples were stored at -
80°C until used for analyses.  
 At the end of the 6 h infusion, piglets were anaesthetized with 1.5% isoflurane 
mixed with oxygen (1.5 l/mim) by mask. The abdomen was opened and tissue 
samples were obtained from the pancreas, liver and kidney, which were quickly 
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freeze-clamped in liquid nitrogen. Samples of other tissues (biceps femoris muscle) 
were then removed and freeze-clamped. A 30 cm long section of proximal jejunum 
was removed, flushed with ice-cold saline, and the mucosa was scraped from the 
muscularis using a glass microscope slide and freeze-clamped. All samples freeze-
clamped time was recored and stored at -80°C until further analysis. 
 
Figure 2. 1: L-[methyl-
3
H] methionine infusion and blood sampling protocol 
 
2.4. Analytical procedures 
2.4.1. Plasma and tissue amino acid concentrations and radioactivity associated 
with methionine 
2.4.1.1. Plasma amino acids analysis 
 Plasma amino acid concentrations were measured by reverse-phase high-
performance liquid chromatography (HPLC) following derivatization with 
phenylisothiocyanate (PITC) (Thermo Scientific, USA) (Bidlingmeyer et al., 1984). 
Briefly, 100 µl of plasma was mixed with 20 µl of 2.5 µmol/ml norleucine internal 
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standard (Sigma Aldrich, Oakville, Canada) and 1 ml of 0.5% trifluoroacetic acid 
(TFA) (Sigma Aldrich, Oakville, Canada) in methanol (MeOH) (Fisher Scientific, 
Whitby, Canada) in a micro centrifuge tube, to precipitate proteins. The samples were 
vortexed and centrifuged at 2655 x g for 5 min. Then the supernatant was poured into 
a plastic tube and flash frozen in liquid nitrogen and lyophilized overnight in a freeze 
dryer (Thermo Savant, Canada). One-hundred  microliters  of 2:2:6 triethylamine 
(TEA) (Sigma Aldrich, Oakville, Canada): MeOH: water was added to each sample 
followed by freeze drying for ~1 h. Samples were then incubated for 35 min at room 
temperature with 50 µl of 1:1:7:1 solution of water: TEA: MeOH: 
phenylisothiocyanate (PITC). The labelling with PITC was stopped by flash freezing 
with liquid nitrogen and then placed on a freeze dryer overnight. Samples were re-
suspended in 200 µl of sample diluent (710 mg of Na2HPO4 (Sigma Aldrich, Oakville, 
Canada) in 1 liter of water, pH 7.4 with 10% H3PO4 acid; 5% of the volume was 
replaced with acetonitrile (Fisher Scientific, Whitby, Canada)).   
 Forty microliters of each sample was injected into a reverse-phase C18 Pico-
Tag column (Waters, 60Å, 4 µm 3.9 X 300 mm) connected to a HPLC system. The 
HPLC system consisted of a Waters 1525 Binary HPLC pump, Waters 2487 Dual λ 
absorbance detector and Waters 717 plus Auto sampler (Waters Corporation, Milford, 
MA, USA). The column temperature was maintained at 46 
o
C to facilitate the 
separation of amino acids. Mobile phase A consisted of 70 mM sodium acetate (Fisher 
Scientific, Whitby, Canada) and 2.5% acetonitrile (Fisher Scientific, Whitby, Canada) 
at pH 6.55 and mobile phase B consisted of 45% acetonitrile 15% MeOH and 40% 
water. Mobile phases were filtered through a 0.45 µm MAGNA nylon filter (Canadian 
Life Science, Peterborough, ON, Canada) and degassed using a Waters In Line-
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Degasser AF. The column was allowed to equilibrate with mobile phase A at a rate of 
1 ml/min. The phenylthiocarbamyl amino acids were detected at 254 nm. Peaks were 
integrated using Breeze Software (Waters, version 3.3, 2002, Waters Corporation, 
Woburn MA, USA) and the amino acid concentrations were determined by comparing 
to the area produced by the internal standard. A fraction collector (Waters Fraction 
Collector III) was used to collect the eluent that was associated with methionine peak. 
The radioactivity associated with methionine was determined by liquid scintillation 
counter (Perkin Elmer Tri-Carb 2810, Woodbridge, ON, Canada) after adding 10 ml 
of ScintiVerse (TM) (Fisher Scientific, Whitby, Canada). Unfortunately, sarcosine and 
assiociated radioactivity could not be successfully separated using this method and so 
were not included in this thesis.  
2.4.1.2. Tissue amino acids analysis 
a. Tissue preparation 
 Liver and muscle tissue were homogenized (1:3 w/v) with 2% cold perchloric 
acid  at 50% speed using a mechanical homogenizer for ~45 s and centrifuged at 3000 
x g for 15 min to separate tissue-free amino acids from tissue-bound amino acids. The 
supernatant was collected into a scintillation vial. This step was repeated 3 times for 
the complete separation of tissue free amino acids. Norleucine (25 µmol/ml) was 
added to the scintillation vial as an internal standard and stored at -80 
o
C until needed. 
The acid-insoluble protein pellet in the tube was used for tissue-bound amino acid 
analysis. 
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b. Tissue-free amino acids 
 The supernatant was neutralized with 2.0 M K2CO3 (12.5% v/v) in a plastic 
tube and centrifuged at 5000 x g for 3 min to separate the supernatant from the 
precipitate. One milliliter of supernatant was added to another plastic tube which was 
flash frozen in liquid nitrogen and placed on a freeze dryer overnight. Then sample 
was derivatized as described in 2.4.1.1.  
c. Tissue-bound amino acids 
 The pellet was re-suspended in 1.0 M NaOH (1:8 w/v) and mixed. The tubes 
were placed in a water bath for ~1.5 h at 37 °C to solubilize the protein. Fifty 
microliters of solubilized protein solution was transferred to a micro centrifuge tube 
and stored at -80 °C to analyze the protein concentration. Protein was re-precipitated 
by adding half of the volume of solubilized protein to cold 20% perchloric acid and 
samples were placed on ice for 20 min. Then samples were centrifuged at 3000 x g for 
15 min and the supernatant was discarded. The internal standard, norleucine (25 
µmol/ml) was added. Then 6.0 M HCl (10 ml/g tissue wt) was added to the tube and a 
glass rod was used to disrupt the pellet, followed by transfer of all contents to a Pyrex 
tube. Then the solution was placed in a 110 °C oven for 24 h to hydrolyze. The 
resulting hydrolysate solution was left to cool overnight. Hydrolysates were brought to 
a final volume of 25 ml with HPLC water. One milliliter was then transferred into a 
plastic tube using a 0.45 µm PTFE syringe filter (Canadian Life Sciences, Canada) 
and tubes were placed in a vacuum oven overnight, and were subsequently derivatized 
as described above (see 2.4.1.1). Muscle samples were directly hydrolyzed with HCl 
after adding the internal standard to the insoluble protein pellet; a solubilized protein 
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sample was not needed for this tissue. The radioactivity associated with methionine 
was determined by HPLC as described above (see 2.4.1.1). 
2.4.2. Analyses of transmethylation products 
2.4.2.1. Determination of creatine concentration and specific radioactivity 
 Tissue creatine concentration was determined using a modified method by 
Lamarre (Lamarre et al., 2010). Tissue was homogenized for 45 s in 50 mM Tris 
buffer (pH 7.4) (0.2/0.9 w/v) and left at room temperature for 20 min to allow for 
complete conversion of phosphocreatine to creatine. Homogenates were transferred to 
a 1.5 ml micro centrifuge tube and TFA (97% minimum) was added to the samples 
which were set on ice. After 10 min, samples were centrifuged at 3825 x g at 4 °C for 
10 min. Samples were then filtered using a Bond-Elut C18 solid phase extraction 
cartridge and were separated via HPLC using porous graphitized carbon column 
(Hypercarb, 7 µm, 100 X 4.6 mm, Thermo Scientific, Canada). The peak was detected 
using a Waters 2487 Dual λ absorbance detector at an absorbance of 210 nm. An 
isocratic mobile phase of 0.1% TFA and 3% MeOH was used with a flow rate of 1 
ml/min and run time of 20 min. A standard curve was used for quantification and 
peaks were determined using Breeze Software (Waters, version 3.3, 2002, Waters 
Corporation, Woburn, MA, USA). The creatine fraction was collected and 
radioactivity of creatine was determined using a liquid scintillation counter as 
described above (2.4.1.1) 
2.4.2.2. Determination of phosphatidylcholine concentration and radioactivity 
 Lipids were extracted from liver by using Folch method (Folch et al., 1957). 
One-hundred milligram of liver was homogenized with 300 µl of 50 mM NaCl in a 
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glass culture tube and transferred to a Pyrex tube. One and a half milliliters of 
chloroform and methanol (2:1) was added and samples were extensively vortexed and 
left at 4 
o
C overnight. After overnight extraction, samples were centrifuged at 2000 x 
g for 10 min and the lower organic layer was removed and evaporated under nitrogen 
gas for 15-20 min. The residue was re-dissolved in 100 µl isopropanol (99.9%) (Fisher 
Scientific, Whitby, Canada). Ten microlilers of samples were applied onto a thin layer 
chromatography (TLC) silica gel 60 plate (EMD, Millipore Corporation, Billerica, 
MA, USA). The plate was inserted in a saturated TLC chamber (with 
chloroform/methanol/acetic acid (17.4 M)/water, 25:15:4:2) and left until the mobile 
phase migrated to the top of the plate. Iodine was used for visualization of the 
corresponding bands to the PC and PE standards.  The PC and PE bands were scraped 
into an acid-washed Pyrex tube containing 300 µl of perchloric acid. The tubes were 
heated at 180 
o
C for ~2 h until no dark colour was visible. Samples were cooled to 
room temperature.  
 PC and PE were quantified via measuring total phosphate using a modified 
Bartlett method (Bartlett, 1959). Phosphate standards were made from stock solutions 
containing KH2PO4 in H2SO4 (1 M) solution. Fifty microliters of 5% ammonium 
molybdate and 50 µl of a 1-amino-2-naphthol-4-sulfonic acid solution (1.0 g 1-amino-
2-naphthol-4-sulfonic acid in 390 ml of 15% sodium metabisulfite plus 10 ml of 20% 
sodium sulfite) were added to samples and standards. Then samples and standards 
were extensively vortexed and placed in a boiling water bath for 12 min to allow 
colour development. A Thermo Spectronic Scientific Bio Mate 3 spectrophotometer 
was used to read the absorbence at 815 nm and a standard curve was used for 
quantification of total phosphorus. A portion of the colour developed sample was used 
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for scintillation counting to determine the radioactive PC using scintillation counter as 
described above (2.4.1.1) 
2.4.2.3. Determination of DNA concentration and radioactive DNA 
 DNA was extracted using the phenol extraction method. Samples were 
homogenized for 45 s in a buffer (50 mM Tris (pH 8), 1% SDS, 100 mM EDTA, and 
100 mM NaCl) and Proteinase K (50 mg/5 ml) (0.4/0.5/0.4 w/v/v). Samples were 
incubated overnight in a water bath at 56 
o
C. An equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) was added to each sample. The samples 
were vigorously shaken and centrifuged for 15 min at 4500 x g. The top aqueous 
phase was transferred to a new tube. This extraction process was repeated several 
times until no protein interface was visible. Finally, chloroform: isoamyl alcohol 
(24:1) was added to the aqueous layer and centrifuged at 4500 x g for 10 min after 
vigorously shaking. The DNA was precipitated using an equal volume of isopropanol 
(99.9%) and 1/5 volume of 1 M sodium acetate and centrifuged at 4500 x g for 5 min. 
DNA pellets were washed twice in 70% ethanol and once in 95% ethanol followed by 
centrifugation for 10 min at 6700 x g. The pellet was dried and re-suspended in 10 
mM Tris buffer (pH 8) with 0.1 mM EDTA. The DNA concentration was determined 
using Thermo Scientific Nano Drop 2000 spectrophotometer and DPM were 
determined with liquid scintillation counter as described above (2.4.1.1). 
2.4.3. Determination of SAM/SAH concentration and radioactive SAM 
 Hepatic SAM and SAH were determined using a method established by 
Ratnam et al. (Ratnam et al., 2006). Tissue was homogenized in cold 8% 
trichloroacetic acid for 45 s and cold centrifuged at 12,000 rpm for 5 min to 
precipitate protein. Then samples were filtered using a 45 µm polytetrafluoroethylene 
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(PTFE) syringe filter (Canadian Life Science, Peterborough, Canada) and analyzed 
using reverse-phase HPLC.  
 Samples were injected into a Vydac C18 reverse phase column (250 X 4.5 
mm, 5 µm Cat#218TP54). A standard curve was used for quantification and peaks 
were determined using Breeze Software (Waters, version 3.3, 2002, Waters 
Corporation, Woburn, MA, USA). Mobile phase was made fresh and filtered with a 
0.45 µm MAGNA nylon filter (Canadian Life Science, Peterborough, Canada).  
Mobile phase A consisted of 50 mM NaH2PO4 and 10 mM heptanesulfonic acid at pH 
3.2 and mobile phase B consisted of 4% acetonitrile. Samples were detected by 
Waters 2487 Dual λ absorbance detector at an absorbance of 258 nm with a flow rate 
of 1 ml/min and run time of 30 min. The SAM fraction was collected and radioactivity 
of SAM was determined via liquid scintillation counter as described above (2.4.1.1). 
2.4.4. Determination of plasma and hepatic homocysteine, cysteine and 
glutathione concentration 
 Plasma and hepatic homocysteine, cysteine and glutathione were determined 
using a modified method by Vester and Rasmussen and Pfeiffer et al. (Vester & 
Rasmussen, 1991; Pfeiffer et al., 1999).  
2.4.4.1. Plasma 
 One-hundred and fifty microliters of plasma was combined with 50 µl of 0.2 
mM 8-amino-naphthalene-1,3,6-trisulfonic acid disodium salt (ANTS) (dissolved in 
0.1 mM borate buffer with 2 mM EDTA at pH 9.5) and 30 μl of tris-(2-carboxyethyl) 
phosphine (TCEP) (100 mg/ml of 1 X PBS (137 mM NaCl, 2.7 mM KCl, 10mM 
Na2HPO4, 2mM KH2PO4, pH 7.4  ) which was vortexed and left at room temperature 
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for 30 min. After 30 min, 125 µl of 0.6 M perchloric acid was added to samples and 
the samples were vortexed and left at room temperature for 10 min followed by 
centrifugation at 4 °C at 4000 x g for 5 min. one-hundred microliters of supernatant 
was then transferred to a flat-top micro centrifuge tube (amber colour) and 200 μl of 2 
M borate buffer (pH 10.5) was added. Samples were derivatized by adding 100 μl of 
7-flurobenzo-2,1,3-oxadiazole-sulfonic acid ammonium salt (SBD-F) solution (1 
mg/ml SBDF in 0.1 M borate buffer with 2 mM EDTA at pH 9.5). Samples were 
covered with aluminum foil and vortexed. Then samples were incubated at 60 °C in a 
water bath for 60 min. Samples were then removed and placed on ice for 5 min and 
subsequently filtered using a 45 µm PTFE syringe filter (Canadian Life Science, 
Peterborough, Canada) and analyzed using reverse-phase HPLC. Samples were 
injected into a YMC-Pack Pro C18 column (150 X 4.6 mm I.D, 3 µm; YMC America, 
Inc, Allentown, PA, USA) and homocysteine, cysteine and glutathione were separated 
via reverse phase HPLC using a dual mobile phase system (Mobile phase A: 980 ml 
33.33 mM sodium acetate trihydrate in 66.66 mM glacial acetic acid (pH 4) mixed 
with 20 ml of 100% methanol and mobile phase B: 800 ml 33.33 mM sodium acetate 
trihydrate in 66.66 mM glacial acetic acid (pH 4) mixed with 200 ml of 100% 
methanol). Samples were detected by Waters 474 Scanning fluorescence detector at 
515 nm emission and 385 nm excitation. The run time for each sample was 20 min 
with a flow rate of 1 ml/min. The ANTS was used as internal standard for 
quantification. Data were obtained using Empower 2 software (Waters, Milford, MA, 
USA).   
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2.4.4.2. Liver 
 One-hundred milligrams of tissue was combined with 500 μl of 0.1 M 
potassium borate buffer (pH 9.5) in 2 mM EDTA and 50 μl of internal standard (2-
mercaptopropionyl-glycine) followed by homogenization for 30 s. Then 50 μl of 
TCEP (32 µg/ml in 0.1 M potassium borate) was added and left at room temperature 
for 30 min after vortexing. After 30 min, 150 µl of 70% perchloric acid was added and 
mixed followed by centrifugation at 4000 x g for 6 min. Five-hundred microliters of 
supernatant was neutralized with 35 µl of 2 M KOH followed by derivatization with 
SBD-F and analyzed using reverse-phase HPLC, as described above (see 2.4.4.1). 
2.4.5. Determination of plasma creatine and creatinine 
 Plasma creatine concentration was determined using a modified method by 
Lamarre (Lamarre et al., 2010). Plasma, 50 mM Tris buffer (pH 7.4) and TFA 
(3:2:0.5) were mixed together in a micro centrifuge tube and set on ice for 10 min. 
After 10 min, samples were centrifuged at 4000 x g for 10 min at 4
o
C.  Creatine and 
creatinine concentration, and specific radioactivity of creatine were determined as 
described above (see 2.4.2.1). 
2.4.6. Determination of plasma and tissue GAA concentration 
 Tissue and plasma GAA was determined according to the method of 
Buchberger and Ferdig (Buchberger & Ferdig, 2004). 
2.4.6.1. Plasma GAA 
 Two-hundred microliters of plasma was mixed with 14 µl of 30% perchloric 
acid and placed on ice for 15 min followed by centrifugation at 15,000 x g for 8 min at 
4 
o
C. One-hundred and fifty microliters of supernatant was transferred to a micro 
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centrifuge tube and 22.4 µl of 20% KOH was added. Then samples were placed on ice 
for 15 min followed by centrifugation at 10,000 x g for 5 min. After centrifugation, 
150 µl of supernatant was used for derivatization with ninhydrin (see section 2.4.6.3).  
2.4.6.2. Tissue GAA 
 Tissue was homogenized with cold 1 M perchloric acid (1:4 w/v) followed by 
centrifugation at 4 
o
C for 20 min at 15,250 x g. Supernatant was transferred to a tube 
quantitatively followed by adding of 50% K2CO3 and 20% KOH to neutralize (pH 
6.5-7) the samples. Samples were centrifuged again for 10 min at 10,600 x g at 4 
o
C. 
Two-hundred microliters of supernatant was used for derivatization with ninhydrin 
(see section 2.4.6.3).  
2.4.6.3. Derivatization with ninhydrin 
 Samples, 1.3 M KOH and 0.9% ninhydrin (4:3:1.5) were mixed together and 
left at room temperature for 15 min. Five percent ascorbic acid and 5 M phosphoric 
acid (1:1) were added to samples and mixed followed by incubation in a 90 
o
C water 
bath for 30 min. After derivatization, samples were cooled and filtered using a 0.45 
µm PTFE syringe filter (Canadian Life Science, Peterborough, Canada). Samples 
were injected into a YMC-Pack Pro C18 column (150 X 4.6 mm I.D, 3 µm; YMC 
America, Inc, Allentown, PA, USA) and derivatized GAA was separated via reverse-
phase HPLC using a dual buffer system (Mobile phase A: 50 mM formic acid and 
mobile phase B: 100% methanol). Samples were detected by Waters 474 scanning 
fluorescence detector at 470 nm emission and 390 nm excitation.  The run time for 
each sample was 32 min with a flow rate of 1 ml/min. A standard curve was used for 
quantification and peaks were determined using Breeze Software (Waters, version 3.3, 
2002, Waters Corporation, Woburn, MA, USA).   
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2.4.7. Determination of hepatic GAMT activity 
 GAMT activity was measured using fresh liver samples using the method of 
Ogawa et al. (Ogawa et al., 1983). Liver tissue was homogenized with a buffer 
solution (1:5 w/v) consisting of 0.25 M sucrose, 1 mM EDTA and 10 mM HEPES 
(pH 7.2), Homogenates were centrifuged at 100,000 x g at 4 ºC for 1 h and the 
supernatant was used to determine GAMT activity.  Briefly, 10 µl supernatant was 
combined with 350 µl of tris-β-mercaptoethanol solution (100 mM Tris buffer (pH 
7.4), 20 mM 2-mercaptoethanol) and 50 μl S-adenosylmethionine solution (8.8 mg 
SAM in 1 ml of water and 1 ml of tris-β-mercaptoethanol buffer) followed by 
incubation at room temperature for 10 min. The assay was started by addition of 10 µl 
of GAA (4.68 mg of GAA in 1 ml of water and 1 ml of tris-β-mercaptoethanol buffer) 
followed by incubation at 37 
o
C for 20 min. Blanks for the assay did not contain 
supernatant. At the end of 20 min of incubation, the assay was stopped by addition of 
750 μl of 15% (w/v) trichloroacetic acid and samples were kept on ice for 10 min. 
Then 720 μl of 1 M Tris (pH 7.4) was added for neutralization followed by 
centrifugation at 10,000 x g for 5 min. Four-hundred microliters of supernatant was 
derivatized as described above (2.4.6.3) to measure creatine production in order to 
determine GAMT activity.  
2.4.8. Determination of muscle metabolites 
 Muscle metabolites (phosphocreatine, ATP and ADP) were determined using a 
modified method by Volonte et al. (Volonté et al., 2004). Briefly 250 mg of the biceps 
femoris muscle  was homogenized with 1 ml of 0.4 M perchloric acid followed by the 
addition 375 µl of 1 M KOH for neutralization. Samples were centrifuged at 3000 x g 
for 5 min. Then samples were filtered using a 45 µm PTFE syringe filter (Canadian 
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Life Science, Peterborough, Canada) and injected into a Waters Symmetry C18 
column (100Å, 5µm, 4.6 X 150 mm). The peak was detected using Waters 2487 Dual 
λ absorbance detector at an absorbance of 220 nm. An isocratic mobile phase of 215 
mM potassium dihydrogen phosphate, 2.3 mM tetrabutylammonium hydrogen sulfate 
(TBASH), 4% acetonitrile and 0.4% potassium hydroxide (1 M) was used with a flow 
rate of 1 ml/min and run time of 20 min. Standard curves were used for quantification 
and peaks were determined using Breeze Software (Waters, version 3.3, 2002, Waters 
Corporation, Woburn, MA, USA). 
2.5. Calculations 
 Specific radioactivity (SRA) of the transmethylation products, methionine and 
SAM were expressed as DPM/nmol. The mean of the plasma SRA of methionine was 
calculated for data between 4 to 6 h of the infusion. All mean SRAs included ≥ 4 
times points. Methionine plateaus were confirmed by regression analysis by 
determining that the slope was not different from zero. Methionine flux was calculated 
using following equation.  
Flux (µmol.kg
-1
.h
-1
) = Methionine dose rate (DPM.kg
-1
.h
-1
)/Mean SRA of methionine 
at plateau (DPM/µmol)  
Fractional synthetic rate (FSR) of the transmethylation products and protein synthesis 
were calculated using following equation.  
Fractional Synthetic Rate (%/h) = SRA of product/SRA of precursor*100/t 
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SRA of hepatic SAM was used as the precursor for calculation of fractional synthetic 
rate of transmethylation products, but SRA of the tissue-free methionine was used to 
calculate tissue specific protein synthesis, with "t" being the duration of labelling in 
hours.  
Proprotion of the 
3
H-methyl products remaining in the liver at the end of study was 
calculated using following equation.  
% = (DPM product/g of tissue)/ (DPM sum of all measured products/g of tissue)*100 
 
2.5. Statistical analysis 
 Data were analyzed by one-way ANOVA with Newman-Keuls multiple 
comparisons post-hoc test using GraphPad Prism 5 (Graph Pad Software, San Diego, 
CA, USA). The alpha level was set at 0.05. All data were reported as mean ± standard 
deviation.  
 
40 
 
3. Results 
  This study was designed for two major outcomes: whole body stable isotope 
analysis (completed by another graduate student) and tissue specific transmethylation 
(subject of this thesis). Based on the sample size calculation, it was decided to have a 
sample size of 6 per group. However, steady state kinetics were not achieved for the 
stable isotope infusions in the first set of pigs, so we added another set of pigs. This 
allowed a sample size of 7 per group for transmethylation outcomes, but one of the 
piglets from Base-GAA group did not complete the experiment because it had a 
volvulus and died during the adaptation period. All other piglets were healthy during 
the study period.  
3.1. Growth and liver to body weight ratio 
 
Figure 3.1: Effects of different test diets on weight gain in neonatal piglets. 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine 
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Figure 3.2: Effects of different test diets on liver to body weight ratio in neonatal 
piglets. 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine 
 There were no differences in animal body weight gain among groups after five 
days of test diets (Figure 3.1). The ratio of liver weight to body weight at the time of 
necropsy also did not differ significantly among groups (Figure 3.2).   
3.2. Plasma amino acids 
 Plasma creatine was higher when creatine was added to the base diet of piglets 
(Table3.1). Supplementing GAA led to higher plasma creatine concentration only 
when methionine was excess in the diet compared to the Base-GAA diet. An excess 
methionine and arginine level in the diet led to higher plasma creatine concentrations 
compared to the Base and Base-GAA groups.   
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Table 3.1: Plasma concentration of metabolites after 5 days of treatment 
 
Columns represent means (µM) (± standard deviations). One-way ANOVA followed by Newman-
Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means not 
sharing a superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine 
 Diet Treatment 
 
Base Base-+GAA Base+ CRE Excess 
Arg/Met 
GAA /Excess 
Met 
Sulfur Amino Acid Metabolites  
Methionine 150±53
a
 121±35
a
 152±31
a
 226±56
b
 233±59
b
 
Homocysteine 20±7.9
a
 18±7.4
ab
 11±2.0
b
 10±3.0
b
 14±4.4
ab
 
Cysteine 168±20
a
 178±45
a
 154±23
a
 130±37
b
 158±32
a
 
Taurine 170±28
a
 165±25
a
 167±29
a
 240±49
b
 253±27
b
 
Glutathione 2.22±1.34 2.09±2.01 1.96±0.97 0.85±0.26 1.61±0.55 
Glycine 1679±615
a
 1636±425
a
 1636±249
a
 1004±166
b
 1584±201
a 
Serine 1098±323
a
 1003±247
a
 1029±220
a
 574±125
b
 874±238
ab
 
Indispensable Amino Acids 
Arginine 71±19
a
 71±23
a
 83±21
a
 427±97
b
 71±16
a
 
Histidine 90±29 86±20 116±33 80±14 105±15 
Isoleucine 251±50 238±27 257±30 230±47 240±74 
Leucine 605±189 531±103 584±96 521±87 560±138 
Lysine 484±98 464±126 438±129 343±95 472±145 
Phenylalanine 119±26 125±15 124±18 151±20 129±32 
Threonine 535±71 515±124 597±140 451±130 480±118 
Tryptophan 84±20 80±20 81±19 87±23 80±34 
Valine 517±91 486±41 503±78 489±80 469±75 
Dispensable Amino Acids  
Alanine 1789±596
a
 1423±332
a
 1528±420
a
 607±112
b
 1538±392
a
 
Aspartate 22±9.8 19±10 22±10 18±9.9 28±6.5 
Hydroxyproline 107±28 90±23 89±33 80±25 88±15 
Proline 811±214 749±128 837±202 892±257 840±186 
Tyrosine 160±88 135±52 118±26 158±45 114±26 
Glutamate 121±21 120±49 152±39 127±39 165±40 
Glutamine 455±111
a
 338±102
a
 426±93
a
 168±93
b
 367±115
a
 
Citrulline 177±48 149±62 128±45 97±39 141±62 
Ornithine 80±16
a
 83±14
a
 84±35
a
 191±60
b
 73±22
a
 
Other Metabolites  
Creatine 130±19
a
 129±44
a
 364±81
b
 284±141
b
 325±63
b
 
Creatinine 30±4
a
 32±4
a
 56±14
b
 36±6
a
 38±7
a
 
GAA 5.9±1.8
a
 6.1±2.1
a
 8.0±4.6
a
 12±4.3
b
 6.0±1.8
a
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 A deficient dietary methionine level led to decreased plasma methionine and 
taurine concentrations compared to piglets on diets with excess methionine (Table 
3.1). Higher plasma taurine concentration with excess dietary methionine diet could 
suggest that there is lower synthesis of taurine in piglets on methionine-deficient diets. 
Arginine deficiency in the diet led to a decrease in plasma arginine, ornithine and 
GAA concentrations. Piglets with excess dietary arginine showed a reduction of 
plasma glycine concentration compared to piglets in arginine-deficient groups. Piglets 
on an arginine-deficient diet had higher plasma glutamine concentrations when 
compared to the group with excess arginine. Interestingly, GAA supplementation did 
not increase plasma GAA concentration in Base-GAA and GAA/Excess Met groups.  
However, the plasma GAA concentration was higher in the group that received Excess 
Arg/Met. The plasma homocysteine concentration was lower in the Base-CRE and 
Excess Arg/Met groups compared to the Base group. There were no differences in the 
plasma glutathione concentration among groups. The group that received Excess 
Arg/Met had lower plasma cysteine compared to other groups. The plasma serine was 
lower in Excess Arg/Met group compared to Base, Base-GAA and Base-CRE groups 
but not different from the GAA/Excess Met group. 
3.3. Hepatic free amino acids and metabolites 
 Unlike plasma concentrations, the hepatic methionine concentration did not 
change in piglets with different levels of dietary methionine (Table 3.2). However, 
hepatic SAM and taurine concentrations were reduced in methionine-deficient groups 
when compared to groups with excess methionine.  
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Table 3.2: Hepatic concentration of free amino acids at the end of study 
Columns represent means (nmol/g) (± standard deviations). One-way ANOVA followed by Newman-
Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means not 
sharing a superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine; PC, Phosphatidylcholine; 
PE, Phosphatidylethanolamine; SAH, S-adenosylhomocysteine;  SAM, S-adenosylmethionine 
* Hepatic GAA data were analyzed by O. Chandani Dinesh for her thesis studies.  
 Diet Treatment 
 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA /Excess 
Met 
Sulfur Amino Acid Metabolites 
Methionine 109±24 106±25 124±33 125±40 133±38 
SAM 34±12
a
 35±11
a
 36±11
a
 119±9
b
 76±16
c
 
SAH 21.9±2.7
a
 22.5±3.9
ab
 20.0±3.7
a
 26.8±4.1
b
 24.5±1.3
ab 
SAM/SAH 1.6±0.6
a
 1.6±0.6
a
 1.8±0.6
a
 4.5±0.8
b
 3.1±0.7
c 
Homocysteine 438±112 497±60 488±76 409±101 437±77 
Cysteine 9354±2172 10470±1635 10049±2543 9041±2990 7487±1545 
Taurine 7676±1006
a
 7720±2177
a
 7361±1058
a
 9812±2159
b
 10132±1116
b
 
Glutathione 18806±5392 17436±4252 16332±5070 22061±5138 21887±3373 
Glycine 1446±247
a
 1239±55
a
 1256±235
a
 573±210
b
 1181±380
a
 
Serine 4233±1085
a
 4205±942
a
 3892±1073
a
 3083±651
ab
 2638±536
b
 
Indispensable Amino Acids 
Arginine 218±28 211±90 230±49 251±58 238±83 
Histidine 370±31 358±46 375±83 395±54 400±71 
Isoleucine 246±29 235±36 256±36 236±35 246±53 
Leucine 521±62 489±90 532±102 505±81 503±118 
Lysine 788±90 669±85 750±151 677±172 655±206 
Phenylalanine 135±13 138±18 142±23 153±24 138±31 
Threonine 537±81 546±98 591±122 595±128 455±100 
Valine 453±49 442±44 451±58 455±64 433±79 
Indispensable Amino Acids 
Alanine 2489±457 2061±713 2213±587 1564±512 2417±666 
Aspartate 1042±195 1042±207 1090±250 915±260 993±327 
Hydroxyproline 137±47 127±33 125±37 118±23 115±16 
Proline 985±257 1028±322 1011±300 1481±633 1082±219 
Tyrosine 193±42 164±39 153±25 180±73 148±51 
Glutamate 1795±398 2065±430 2002±403 1503±461 1503±415 
Glutamine 1446±247
a
 1239±55
a
 1256±235
a
 597±177
b
 1181±380
a
 
Citrulline 159±51 138±30 159±52 123±37 117±22 
Ornithine 358±89
a
 348±98
a
 379±158
a
 1256±304
b
 318±128
a
 
Other Metabolites 
Creatine 918±317
a
 978±855
a
 2694±1177
ab
 3767±2012
bc
 5733±2781
c
 
GAA* 18±2 18±5 12±2 16±4 19±7 
PE 9057±3104 8465±2653 8299±2319 7327±1617 6962±943 
PC 14409±3736 15758±3684 14767±3410 17079±4067 16848±3611 
PE/PC 0.71±0.34
a
 0.52±0.12
ab
 0.57±0.17
ab
 0.44±0.12
ab
 0.40±0.10
b
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 Hepatic SAM concentrations were reduced when piglets on excess methionine 
were supplemented with GAA compared to piglets with excess dietary Arg/Met. 
There was a reduction in SAM:SAH ratio in methionine-deficient groups compared to 
groups with excess methionine. A reduction in the SAM:SAH ratio was observed 
when the excess methionine diet was supplemented with GAA compared to the group 
with Excess Arg/Met. Hepatic SAH concentration was higher in Excess Arg/Met 
group compared to Base and Base-CRE groups. 
 Supplementing GAA led to higher hepatic creatine concentration only when 
methionine was excess in the diet when compared to the Base-GAA diet. Also, excess 
arginine and methionine diet led to higher hepatic creatine concentration compared to 
the base diet. Supplementation of the base diet with creatine resulted in a ~3-fold 
increase in hepatic creatine but there was also a 4-5-fold increase in hepatic creatine in 
Excess Arg/Met and GAA/Excess Met groups compared to the base group.  
 The hepatic concentration of arginine did not change with dietary arginine 
levels. However, hepatic ornithine concentration was lower with arginine-deficient 
diets. Also, there was a higher level of hepatic glutamine in arginine-deficient groups 
compared to the group with excess arginine. Excess arginine in the diet led to a 
reduction in hepatic glycine concentration when compared to other groups. Serine 
concentrations were lower in GAA/Excess Met groups compared to Base, Base-GAA 
and Base-CRE groups. There were no differences in hepatic PC and PE concentration 
among groups but there was a reduction of PE: PC ratio in GAA/Excess Met group 
compared to the Base group. Similar to findings in plasma, GAA supplementation did 
not increase hepatic GAA concentration in Base-GAA and GAA/Excess Met groups. 
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3.4. Skeletal muscle free amino acids and energy metabolites 
 
Table 3.3: Muscle concentration of metabolites 
Columns represent means (nmol/g) (± standard deviations). One-way ANOVA followed by Newman-
Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means not 
sharing a superscript letter were different. 
ADP, Adenosine 5′-diphosphate; ATP, Adenosine 5′-triphosphate; Arg, Arginine; CRE, Creatine; 
GAA, Guanidinoacetic acid; Met, Methionine 
 
 A deficient level of dietary methionine led to lower muscle methionine 
concentrations compared to diets with excess methionine (Table 3.3). In contrast to 
plasma and liver concentrations, there were no differences in muscle taurine and 
creatine among groups. Also, there were no differences in muscle phosphocreatine, 
ATP and ADP among groups. Excess arginine in the diet led to a reduction in muscle 
glycine concentration compared to other groups, perhaps suggesting that glycine was 
consumed during creatine synthesis.   
 
Diet Treatment 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA/ Excess 
Met 
Methionine 106±35
a
 116±23
a
 122±19
a
 188±36
b
 179±28
b
 
Creatine 25375±5394 26132±917 25977±2389 28439±2953 27127±5885 
Taurine 5285±1045 5155±790 4947±743 5221±743 5192±869 
Glycine 2219±484
a
 1927±487
a
 2190±654
a
 610±325
b
 1735±596
a 
Phosphocreatine 5535±1820 5537±2403 6501±2615 5653±2994 5539±2691 
ADP 680±116 731±104 653±116 776±238 659±158 
ATP 3052±370 3544±255 3128±421 3150±462 3344±414 
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3.5. Kidney creatine and GAA concentrations 
 
Table 3.4 Kidney concentration of metabolites 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. Means not sharing a 
superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine; GAA; Guanidinoacetic 
acid 
* Kidney GAA and creatine concentrations were analyzed by O. Chandani Dinesh for her 
thesis studies.  
 
 A deficient level of dietary arginine led to lower kidney GAA concentrations 
compared to diets with excess arginine. Supplementing GAA led to higher renal 
creatine concentration only when methionine was excess in the diet when compared to 
the Base-GAA diet. Also, excess arginine and methionine in diet led to higher renal 
creatine concentration compared to the base diet. Supplementation of the base diet 
with creatine resulted in a ~3-fold increase in renal creatine. 
  
 
Diet Treatment 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA/Excess 
Met 
Creatine* 363±105
a
 443±291
a
 1009±427
b
 952±437
b
 1135±461
b
 
GAA* 345±113
a
 388±187
a
 259±129
a
 645±344
b
 274±82
a
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3.6. Methionine kinetics 
3.6.1. Plasma methionine kinetics and methionine flux 
3.6.1.1. Methionine enrichment 
 
 
Figure 3.3: Plasma methionine SRA over time in representative pigs from each 
test group that received gastric infusions of L-[methyl-
3
H] methionine at a 
constant rate of 30 µCi/kg/h. 
(A) Base, (B) Base+GAA, (C) Base+CRE, (D) Excess Arg/Met, (E) GAA/Excess Met 
Arg, Arginine; DPM, Disintegrations per minute; CRE, Creatine; GAA, Guanidinoacetic acid; Met, 
Methionine; SRA, Specific radioactivity 
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  As shown in Figure 3.3, a steady-state of plasma isotopic enrichment of L-
[methyl-
3
H] methionine was achieved during 4 h of constant infusion. Figure 3.4 
shows the average methionine SRA in plasma for each group. The mean plasma 
enrichment between 4 to 6 h was used to calculate the methionine SRA in plasma and 
methionine flux. There were no differences in either mean methionine SRA or 
methionine flux between methionine deficient and methionine excess diets. 
 
 
Figure 3.4: The mean plasma SRA of methionine between 4 and 6 h of infusion of 
L-[methyl-
3
H] methionine (ie at steady state). 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. 
Arg, Arginine; DPM, Disintegrations per minute CRE, Creatine; GAA, Guanidinoacetic acid; Met, 
Methionine; SRA, Specific radioactivity 
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Figure 3.5: Whole body methionine flux of different diet groups. 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine 
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3.6.1.2. Plasma creatine specific radioactivity 
 
 
Figure 3.6: SRA of plasma creatine in different diet groups at the end of L-[methyl-
3
H] methionine infusion for 6 h. 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. Significant differences 
between groups are shown by the different letters above each column. 
Arg, Arginine; DPM, Disintegrations per minute CRE, Creatine; GAA, Guanidinoacetic acid; Met, 
Methionine; SRA, Specific radioactivity 
 
 The SRA of the plasma creatine was higher in Base and Base-GAA groups 
compared to Excess Arg/Met and GAA/Excess Met groups. Supplementing creatine 
led to lower plasma creatine SRA compared to other groups (Figure 3.6). 
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3.6.2. Hepatic methionine kinetics 
3.6.2.1. Specific radioactivity 
 
Table 3.5: Specific radioactivity (SRA) of hepatic metabolites 
Columns represent means (DPM/nmol) (± standard deviations). One-way ANOVA followed by 
Newman-Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means 
not sharing a superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine; PC, Phosphatidylcholine; 
SAM, S-adenosylmethionine 
 
 There were no differences in the SRA of hepatic tissue free methionine, 
hydrolyzed (ie protein-bound) methionine or SAM among groups. In creatine 
supplemented pigs, the SRA of hepatic creatine was low compared to other groups. 
The SRA of the hepatic PC was higher in Base-CRE, Excess Arg/Met and GAA/ 
Excess Met groups compared to other groups. Groups with excess methionine had a 
higher SRA of hepatic DNA compared to methionine-deficient groups.  
  
 Diet Treatment 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA /Excess 
Met 
Free Met 81±8 70±37 76±32 93±16 95±16 
Protein-
bound Met  
11.0±1.9 10.9±2.8 13.9±1.7 10.7±2.5 10.2±2.2 
Creatine  78±14
a
 65±13
a
 47±6
b
 73±12
a
 76±14
a 
PC  10±3
a
 12±5
a
 19±6
b
 25±7
b
 22±5
b 
SAM  119±28 123±25 145±48 127±16 150±21 
DNA 0.80±0.08
a
 0.93±0.08
a
 0.91±0.07
a
 1.15±0.25
b
 1.21±0.19
b 
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3.6.2.2. Hepatic fractional synthetic rate 
 
Table 3.6: Fractional synthetic rate of transmethylation products and protein in 
liver 
Columns represent means (%/h) (± standard deviations). One-way ANOVA followed by Newman-
Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means not 
sharing a superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine; PC, Phosphatidylcholine 
 
 The fractional synthetic rate of creatine was lower in piglets supplemented 
with creatine when compared to other groups.  The fractional synthetic rate of hepatic 
PC was significantly higher in Excess Arg/Met group compared to other groups. 
There were no differences in the fractional synthetic rate of hepatic protein and DNA 
among groups.  
 
  
 
Diet Treatment 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA/Excess 
Met 
Creatine 11.4±3.0
a
 9.3±2.8
a
 5.7±1.1
b
 9.8±2.7
a
 8.7±2.5
a
 
PC 1.52±0.63
a
 1.75±0.61
a
 2.22±0.90
a
 3.32±1.01
b
 2.46±0.64
a
 
Protein 2.3±0.5 2.7±1.3 2.7±1.5 2.0±0.6 1.8±0.5 
DNA 0.045±0.010 0.050±0.011 0.048±0.012 0.059±0.014 0.052±0.009 
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3.6.2.3. 
3
H-Methyl products remaining in the liver at necropsy 
 
Table 3.7: 
3
H-Methyl products remaining in the liver after 6 h constant infusion 
with L-[methyl-
3
H] methionine 
 
Columns represent means (x1000 DPM/g) (± standard deviations). One-way ANOVA followed by 
Newman-Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means 
not sharing a superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA, Guanidinoacetic acid; Met, Methionine; PC, Phosphatidylcholine; 
SAM, S-adenosylmethionine 
 After 6 h, newly synthesized hepatic creatine, derived from L-[methyl-
3
H] 
methionine, was higher in GAA/Excess Met group compared to other groups. Newly 
synthesized hepatic PC, via transmethylation from L-[methyl-
3
H] methionine, was 
higher in Excess Arg/Met and GAA/Excess Met groups compared to the Base and 
Base-GAA groups. In pigs on methionine-deficient diets, newly synthesized L-
[methyl-
3
H] SAM was lower compared to pigs with excess dietary methionine. There 
was a reduction in newly synthesized SAM, derived from L-[methyl-
3
H] methionine 
in GAA/Excess Met group compared to the Excess Arg/Met group. There was higher 
newly methylated DNA, methylated by L-[methyl-
3
H] methionine, in the Excess 
Arg/Met and GAA/Excess Met groups compared to the Base group. There were no 
 Diet Treatment 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA / Excess 
Met 
Creatine  74±35
a
 76±51
a
 114±57
a
 202±148
a
 372±122
b  
PC 137±43
a
 174±85
a
 223±80
ac
 343±58
bd
 287±78
cd 
DNA 7.8±0.7
a
 9.0±1.4
ab
 9.1±1.3
ab
 11.0±3.2
b
 11.0±2.4
b 
Free Met 8.8±2.2 8.5±2.6 8.7±1.7 11.5±4.1 12.4±3.4 
Protein-
bound Met 
66±33 70±32 90±23 67±35 75±34 
SAM 4.0±1.2
a
 4.4±2.0
a
 5.6±3.3
a
 15.0±2.2
b
 11.0±2.2
c
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differences in the newly incorporated tissue free and protein-bound L-[methyl-
3
H] 
methionine among groups.  
Table 3.8: Proportion of the 
3
H-methyl products remaining in the liver after 6 h 
constant infusion with L-[methyl-
3
H] methionine 
Columns represent means (% of total measured 
3
H-products) (± standard deviations). 
Arg, Arginine; CRE, Creatine; DPM, Disintegrations per minute; GAA, Guanidinoacetic acid; Met, 
Methionine; PC, Phosphatidylcholine; SAM, S-adenosylmethionine 
 
 In pigs on methionine-deficient diets, ~20% of the dietary methionine was 
used for protein synthesis and ~75% for transmethylation products (Table 3.8). Also 
notable was that only 40-60% of dietary methionine remained in liver when 
methionine was deficient. When dietary methionine was excess, ~10% of the dietary 
methionine was used for protein synthesis and ~85% for transmethylation products. 
Overall, these data suggest that the vast majority of dietary methionine ends up in 
transmethylation products.  
 
Diet Treatment 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA/Excess 
Met 
Creatine  22±4 27±18 25±11 27±13 48±8 
PC 48±6 46±15 49±10 56±13 38±7 
DNA 3.0±1.4 2.7±1.2 2.1±0.5 1.8±0.4 1.5±0.6 
Free Met 3.3±1.2 2.7±2.1 2.0±0.5 1.9±0.8 1.7±0.5 
Protein-bound Met 22±6 20±10 21±6 10±3 10±4 
SAM 1.4±0.3 1.2±0.3 1.2±0.5 2.6±0.9 1.6±0.6 
Total measured 
3
H-
products (DPMx1000/g) 
299±100 385±150 450±116 650±226 770±171 
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 Supplementation with GAA doubled the proportion of dietary methionine 
ending up in creatine, but only when methyl groups were not limited by low 
methionine. Approximately half of the 
3
H-methyl groups were diverted to PC 
synthesis in all groups, but the proportion in PC was somewhat lower in GAA/Excess 
Met group when creatine synthesis by GAA methylation was facilitated. 
3.6.3. Skeletal muscle methionine kinetics 
3.6.3.1. Specific radioactivity 
 A deficient level of dietary methionine led to a decreased SRA of the tissue 
free methionine but increased the SRA of the protein-bound methionine compared to 
the excess methionine groups.  A similar trend was observed in newly incorporated 
methionine from L-[methyl-
3
H] methionine in muscle tissue free and tissue bound 
methionine (Table 3.10).  
Table 3.9: Specific radioactivity (SRA) of muscle metabolites 
Columns represent means (DPM/nmol) (± standard deviations). One-way ANOVA followed by 
Newman-Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means 
not sharing a superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA; Guanidinoacetic acid; Met, Methionine 
 
 
  
 Diet Treatment 
Base Base+GAA Base+CRE Excess Arg/Met GAA /Excess 
Met 
Free Met 54±15
a
 57±20
a
 56±31
a
 133±41
b
 143±19
b
 
Protein-
bound Met 
6.6±1.3
a
 7.2±1.7
a
 7.1±0.9
a
 3.7±1.5
b
 4.5±0.9
b
 
Creatine 1.8±0.6 1.6±0.5 0.9±0.3 1.4±0.6 1.3±0.4 
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Table 3.10 
3
H-Methyl products found in the muscle after 6 h constant infusion 
with L-[methyl-
3
H] methionine  
Columns represent means (x1000 DPM/g) (± standard deviations). One-way ANOVA followed by 
Newman-Keuls multiple comparisons (α = 0.05) were used to test for differences between diets. Means 
not sharing a superscript letter were different. 
Arg, Arginine; CRE, Creatine; GAA; Guanidinoacetic acid; Met, Methionine 
 
3.5.3.2. Fractional synthetic rate of muscle protein 
 
Figure 3.7: Effect of deficient methionine on protein synthesis. 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. Significant differences 
between groups are shown by the different letters above each column.  
Arg, Arginine; CRE, Creatine; FSR, Fractional synthetic rate; GAA, Guanidinoacetic acid; Met, 
Methionine 
 
 Diet Treatment 
Base Base+GAA Base+CRE Excess 
Arg/Met 
GAA /Excess 
Met 
Free Met 5.4±1.3
a
 6.2±1.2
a
 6.6±3.1
a
 23.8±4.3
b
 25.6±5.3
b
 
Protein-
bound Met 
122±22
a
 131±12
a
 122±24
a
 65±17
b
 88±19
b
 
Creatine 48±12
a
 46±14
a
 22±6
b
 37±15
ab
 33±11
ab
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There were no differences in the SRA of muscle creatine among groups. In 
methionine-deficient pigs, the fractional synthetic rate of protein was ~4-fold higher 
than in pigs with excess methionine.  
 
3.6. Enzyme activities 
 
 
Figure 3.8: Effect of GAA and creatine feeding on liver GAMT activity 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. Significant differences 
between groups are shown by the different letters above each column. 
Arg, Arginine; CRE, Creatine; GAMT, Guanidinoacetate methyltransferase; GAA, Guanidinoacetic 
acid; Met, Methionine 
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Figure 3.9: Effect of GAA and creatine feeding on kidney AGAT activity. 
Columns represent means (± standard deviations). One-way ANOVA followed by Newman-Keuls 
multiple comparisons (α = 0.05) were used to test for differences between diets. Significant differences 
between groups are shown by the different letters above each column. 
Arg, Arginine; AGAT, Arginine:glycine amidinotransferase CRE, Creatine; GAA, Guanidinoacetic 
acid; Met, Methionine 
Remark: Kidney AGAT activity was analyzed by O. Chandani Dinesh for her thesis studies.  
 
 Supplementation with GAA and excess methionine resulted in a significant 
increase of hepatic GAMT enzyme activity (Figure 3.8). Supplementing creatine or 
GAA with excess methionine led to lower AGAT activity compared to Base, 
Base+GAA and Excess arginine and methionine diet (Figure 3.9).   
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4. Discussion 
 When creatine was supplemented to the diet (Miller et al., 1962; Guzik et al., 
2000) or injected intraperitoneally (Baker et al., 1961), it did not induce growth in 
weaning piglets, likely because arginine and methionine, precursors for creatine, were 
not limiting in the first place. In order to observe the sparing effect of creatine or 
GAA, the diets should be marginally deficient in arginine and/or methionine. 
Therefore, in this study using arginine- and methionine-deficient diets, we 
investigated the effects of dietary creatine on sparing methionine and arginine for 
protein synthesis, and of its precursor GAA on sparing arginine for protein synthesis. 
We hypothesized that creatine and GAA supplementation can change the flux of 
transmethylation and protein synthesis in the liver by sparing the methyl groups 
needed from methionine for creatine synthesis. The main objectives of this study were 
to quantify the partitioning of transmethylation reactions in response to dietary GAA 
and creatine supplementation and to quantify the sparing effects of dietary GAA and 
creatine on protein synthesis. 
4.1. Rationale of diet groups 
 The methionine requirement for gastrically-fed piglets is 0.25 g/kg/day 
(Shoveller et al., 2003a). We chose to feed methionine at a rate of 0.20 g/kg/day, 
which is 80% of the piglets' requirement, to marginally impair protein synthesis and 
transmethylation reactions. The effects of this low methionine are evaluated with 
supplementation of GAA, creatine and excess methionine. In suckling piglets, the 
methionine intake from milk is estimated at 27.8 mmol or 4.1 g between 4 to 11 days 
of age (Brosnan et al., 2009). Assuming an average body weight of 2.25 kg at this age, 
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this translates to a whole body methionine requirement of 0.26 g/kg/day, which is 
similar to the empirically determined estimate by Shoveller et al., 2003a)  
 Suckling piglets gain 12.5 mmol of total creatine between 4 to 11 days of age 
(Brosnan et al., 2009). Based on that finding, the total body creatine accretion rate at 
this age is 0.103 g/kg/day; so we infused 0.118 g creatine monohydrate/kg/day to 
account for this creatine accretion rate. Also, creatine down-regulates AGAT activity 
which would increase the arginine available for protein synthesis, provided arginine is 
deficient. Based on this creatine accretion rate, we calculated the amount of GAA that 
is enough to satisfy the amount of creatine that would be consumed and synthesized in 
piglets at this age; the molar equivalent of GAA to satisfy this creatine accretion rate 
is 0.093 g GAA/kg/day. GAA supplementation would also reduce the conversion of 
arginine into GAA, thus leading to further arginine availability for protein synthesis. 
In addition, the amount of methionine needed to convert GAA to creatine in suckling 
piglets is 0.12 g/kg/day (Brosnan et al., 2009). Thus, if creatine is not provided in the 
diet, then the piglet requires approximately 0.38 g methionine/kg/day (0.26 plus 0.12 
g/kg/day) to convert GAA to creatine in the GAA/excess methionine diet. Therefore, 
this ‘excess’ methionine was provided at a rate of 0.5 g/kg/day, which fulfils the 
requirement for the whole body, as well as the methyl groups needed for the 
conversion of GAA to creatine at a normal creatine accrual rate. 
The arginine requirement for piglets is 0.38 g/kg/day (National Research 
Council, 1998), but in enterally-fed piglets receiving a graded dietary concentration of 
arginine, the breakpoint in the plasma concentration was ~0.6 g/kg/day (Brunton; 
unpublished work). Brunton and co-workers also demonstrated that ~0.6 g 
arginine/kg/day is required to maximize muscle protein synthesis in enterally-fed 
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neonatal piglets. Other studies showed that at least 0.2 g/kg/day was needed to avoid 
acute hyperammonemia (Wilkinson et al., 2004; Urschel et al., 2007). Therefore, we 
chose a ‘marginally deficient’ arginine level at a rate of 0.3 g/kg/day, which is 79% of 
NRC requirement.  
The effects of low arginine were tested through comparisons with diets 
supplemented with GAA, creatine or excess arginine. Excess arginine was provided at 
a rate of 1.8 g/kg/day, which was metabolically sufficient for the whole body, and also 
accommodates whole body GAA synthesis, as calculated from creatine accretion 
during this age (Brosnan et al., 2009). The purpose of excess arginine and methionine 
diet was to provide sufficient substrates to synthesize creatine at a maximum level 
without limiting other metabolic pathways. This treatment could be considered a 
‘positive’ control situation with excess nutrients for all metabolic products, while the 
Base treatment can be considered the ‘negative’ control. GAA provided to the liver is 
rapidly converted to creatine with no feedback regulation at GAMT (Da Silva et al., 
2009; McBreairty et al., 2013), which requires excess methyl groups. If methionine is 
limited in the Base-GAA diet, then GAA conversion to creatine could be limited by 
lack of methyl supply; so we supplemented GAA with excess methionine to enable 
creatine synthesis and ensure methionine is available for protein synthesis and for 
other methylated products. 
4.2. Effects of creatine supplementation and methyl demand in neonatal piglets 
 A previous study in piglets reported that creatine synthesis may consume 66 to 
77% of all of the labile methyl groups (Brosnan et al., 2009). Therefore, creatine 
supplementation could increase the availability of methyl groups for other 
transmethylation reactions by reducing the labile methyl groups needed for creatine 
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synthesis. There was no increase in hepatic SAM in creatine supplemented pigs, 
suggesting creatine is not sparing labile methyl groups and expanding the SAM pool. 
We observed a 50% decrease in the fractional rate of de novo creatine synthesis in the 
liver when creatine was fed with the base diet. To support this finding, we also 
observed a similar trend in plasma creatine SRA in the creatine supplemented group 
compared to our base group. Creatine bio-synthesis is regulated by the enzyme 
AGAT. In rats, creatine supplementation down-regulates AGAT activity (McGuire et 
al., 1984; Guthmiller et al., 1994; Edison et al., 2007; da Silva et al., 2013). We also 
noticed a lower activity of AGAT in the kidney of the creatine supplemented group. 
As a result, GAA production should be reduced; but we did not see any reduction in 
plasma GAA or kidney and hepatic GAA in the creatine supplemented group. This 
may be because the amount of creatine fed was not high enough to alter the plasma 
GAA concentration, or more time was needed to see an effect on this outcome. We 
could not expaline the kinetic properties of AGAT as there is no data available on 
Michaelis-Menten constant (Km) of AGAT for pig. In contrast, creatine 
supplementation reduced the plasma GAA concentration in rats (Edison et al., 2007; 
Da Silva et al., 2009) and humans (Derave et al., 2004). In those studies, rats were fed 
4 g/kg of creatine for 2 weeks and humans were fed 20 g/day for 1 week followed by 
5 g/day for 19 weeks, but these creatine supplementation levels are likely higher than 
the respective body accretion rates.  
 Consistent with other studies in rats (Walker, 1979; Da Silva et al., 2009), 
there were no changes in the GAMT activity in the liver with creatine 
supplementation. This suggests that creatine supplementation did not down-regulate 
GAMT activity, in contrast to the down-regulation of AGAT activity. The reduction in 
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plasma homocysteine concentrations in the creatine-supplemented group compared to 
the base group also suggests that less transmethylation occurs with creatine 
supplementation. Consistently, it has previously been shown that dietary creatine 
lowers plasma homocysteine in rats (Stead et al., 2001; Deminice et al., 2009) and 
humans (Korzun, 2003).  
 The fractional synthetic rate of creatine represents the fraction of the total 
creatine pool that was synthesized. The estimated fractional synthetic rate is 
represented by the ratio of the SRAs of creatine and SAM. The lower hepatic 
fractional synthetic rate of creatine in creatine supplemented pigs could be due to 
either less creatine synthesis or due to a larger pool of creatine. However, I did not 
observe any difference in creatine DPM/g of liver in the creatine supplemented group 
compared to the base group, suggesting the larger creatine pool is likely diluting 
newly synthesized creatine thereby reducing its SRA. The similar DPM/g also 
suggests that creatine synthesis as a percent of methionine flux did not change (ie as 
much label ended up in creatine after 6 h regardless of how much creatine was fed). 
Moreover, stable isotope studies on these same animals demonstrated that there was 
no difference in the whole body rate of arginine conversion to creatine or GAA 
conversion to creatine in creatine-supplemented pigs compared to the base group (data 
from O. Chandani Dinesh thesis). Combined, these data suggest that creatine 
supplementation did not alter de novo creatine synthesis flux in spite of a down-
regulation of AGAT specific activity. This disconnect between AGAT activity or 
capacity and actual whole body flux through AGAT warrants further investigation. 
An increase in the SRA of hepatic PC was observed in the creatine 
supplemented piglets compared to the Base group; however, in spite of a similar trend, 
65 
 
the fractional synthetic rate of PC was not different. This higher PC SRA suggests that 
supplementing creatine spares methyl groups for PC synthesis via the PEMT pathway. 
Approximately 70% of the PC synthesis occurs via CDP-choline: 1,2-diacylglycerol 
choline phosphotransferase enzyme. The remaining 30% is synthesized via the PEMT 
pathway (DeLong et al., 1999; Reo et al., 2002; Li & Vance, 2008). Although the 
hepatic total PC concentration was not different in the creatine-supplemented group, it 
is possible that this alternate pathway compensates for higher PC synthesis via PEMT. 
Creatine supplementation did not increase protein synthesis or DNA methylation. This 
observation that creatine can spare methionine for PC synthesis, but not for protein 
synthesis, suggests that hepatic protein synthesis is conserved over transmethylation 
reactions when methionine is limiting. 
Surprisingly, muscle tissue did not accumulate greater creatine in the creatine 
supplemented group. Supplementing creatine led to higher creatine concentrations in 
plasma and the liver, suggesting that the supplemented creatine was absorbed by the 
neonatal intestinal tract. In both animals and humans, total creatine pool in the muscle 
is increased when creatine is continuously supplemented (Harris et al., 1992; Ipsiroglu 
et al., 2001). Since the  storage capacity of creatine is limited in skeletal muscles 
(Harris et al., 1992) and the creatine concentration of biceps femoris muscle is 
relatively high (Mora et al., 2008), it can be speculated that despite the ~2.5 fold 
increase in plasma creatine concentrations, muscle creatine concentration was at a 
maximal creatine storage capacity prior to supplementation. The creatine transporter, a 
high affinity transporter in the plasma membrane, has a Km of 20-50 μM, thus can 
accumulate creatine efficiently into the cell leading to an intracellular concentration in 
muscle in the range of 20-40 mM (Speer et al., 2004). The plasma creatine 
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concentration was 360 µM in the creatine supplemented group, so it was also likely 
that the transporter was saturated, limiting creatine uptake into muscle. Therefore, 
supplementing creatine at a level that fulfills the daily accretion ‘requirement’ to 
marginally methionine deficient neonatal piglets was likely not significant enough to 
affect the massive creatine pool in the muscles in the short time frame of the study. 
Brosnan et al. reported that the liver has the highest GAMT activity in piglets with 
only 3% of that specific activity in muscle (Brosnan et al., 2009). Therefore, muscle 
does not likely synthesize significant amounts of creatine, but should still be the main 
target tissue for creatine synthesized in the liver. Indeed, the pattern of plasma creatine 
SRA matches that of muscle creatine SRA suggesting that creatine in muscle is 
transported from the liver via the plasma. 
4.3. Effects of GAA supplementation and methyl demand in neonatal piglets 
 Creatine synthesis is proportional to GAA availability in rats (Da Silva et al., 
2009) and piglets (McBreairty et al., 2013). The liver is the primary organ for creatine 
synthesis. With GAA supplementation, plasma and liver creatine concentrations were 
3-fold and 5-fold higher, respectively, when the methionine supply was in excess, 
compared to the Base-GAA group. Also, a significantly higher specific activity of 
GAMT in the GAA/Excess Met group compared to the Base-GAA group was 
observed, suggesting that enzyme activity was induced to accommodate the higher 
rate of creatine synthesis. This is best interpreted in terms of the kinetic properties of 
GAMT and the substrate concentrations. GAMT activity in the pig follows Michaelis-
Menten kinetics and Km for SAM is 49 µM and for GAA is 27 µM (Walker, 1979). 
The plasma GAA concentration was ~6 µM in Base-GAA and GAA/Excess Met 
groups, so GAMT was not saturated.  On the other hand, supplementing GAA to 
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methionine deficient diets limited conversion of GAA to creatine according to 
metabolite concentrations. However, there was no increase in the fractional synthetic 
rate of creatine in the GAA/Excess Met group compared to the Base-GAA group, in 
spite of a significantly higher DPM creatine/g of tissue in the GAA/Excess Met group. 
These data suggest that GAA/Excess Met led to rapid creatine synthesis and this 
newly synthesized creatine accumulated to a greater extent in the liver; however, 
when measured as a fraction of the massive creatine pool, the percent of this creatine 
pool synthesized per hour was not different.  
 Interestingly, GAA supplementation did not lead to higher plasma GAA or 
hepatic GAA suggesting that it is utilized immediately in the intestinal tract and/or 
liver to synthesize creatine, when the methyl supply is excess. However, when the 
methyl supply was limited and creatine was not being synthesized, supplemented 
GAA still did not increase the GAA concentration in plasma or liver. It is possible that 
GAA accumulated in other tissues not measured. GAA is known to be neurotoxic to 
the brain (Schulze et al., 1997), so it is also possible that the body rapidly excreted 
unmetabolized GAA via urine or bile to prevent toxicity. In humans, it has been 
shown that GAA is excreted in urine (Ostojic et al., 2013). Although not measured in 
the present study, it would be interesting to see the effect of dietary GAA on urinary 
GAA excretion. 
 GAA can spare arginine for growth in chicks (Almquist et al., 1941). More 
recently, Dilger et al. demonstrated that GAA was as effective as creatine in sparing 
arginine for growth in broiler chicks, but only when arginine is deficient in diets 
(Dilger et al., 2013). In enterally fed piglets, first-pass arginine synthesis does not 
change when arginine is deficient or in excess in the diet (Wilkinson et al., 2004). The 
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lack of change in growth rate in our study suggests that GAA did not spare arginine 
for growth when arginine was deficient. This may be due to the fact that first-pass 
arginine synthesis was sufficient to maintain the growth rate, even with deficient 
dietary arginine. To support this hypothesis, no increases in plasma or hepatic arginine 
concentrations was observed when GAA was supplemented to the arginine deficient 
diet. Interestingly, a 2 h constant infusion of GAA via the portal vein increased 
hepatic arginine in piglets (McBreairty et al., 2013).  This higher hepatic arginine may 
have been utilized for non-protein functions in the liver including urea or polyamine 
synthesis. 
 GAA supplementation was also more successful at increasing hepatic creatine 
concentrations compared to creatine supplementation (Table 3.2). However, similar to 
the effect of creatine supplementation, muscle tissue did not accumulate creatine when 
creatine synthesis was increased in the liver, suggesting that the muscle creatine pool 
is maximized in neonatal piglets, or the pool size is too large to see a difference in 
only 5 days. 
4.4. Methionine metabolism and methyl demand in neonatal piglets 
 Hepatic methionine concentrations did not change with deficient or excess 
dietary methionine. However, hepatic SAM concentration was higher when 
methionine was supplemented, suggesting that excess methionine was rapidly 
converted to SAM, perhaps as a mechanism to prevent hepatic methionine levels from 
becoming toxic. As a result, a higher SAM:SAH ratio was also observed when excess 
methionine was supplemented in the diet, compared to deficient methionine diets. The 
SAM:SAH ratio is often used as a transmethylation index (Rowling et al., 2002). A 
lower ratio suggests a higher transmethylation rate. However, when comparing low 
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and high dietary intakes of methionine, the SAM:SAH ratio is likely dictated by 
methionine supply, rather than transmethylation rate. When comparing the two excess 
methionine diets, significantly lower hepatic SAM and SAM:SAH ratio were 
observed in the GAA/Excess Met diet, compared to the Excess Arg/Met diet, 
reflecting the higher transmethylation flux from GAA to creatine in that diet. 
 Approximately 70% of PC is synthesized via the Kennedy pathway and the 
remaining 30% is synthesized via the PEMT pathway. The hepatic PC concentration 
was similar among methionine-deficient and methionine-excess diets, but there was a 
significantly higher fractional synthetic rate of PC with excess dietary Arg/Met. This 
suggests that PC synthesis via PEMT was higher when the methyl supply was 
expanded with more dietary methionine. Excess Arg/Met led to proportionately more 
methyl incorporation into PC (~56%) versus creatine (~27%) (Table 3.8). This diet 
condition was considered a control situation with excess nutrients. However, 
supplementing GAA to this excess diet significantly reduced the fractional synthetic 
rate of PC in the liver, even though the methyl supply was excess as reflected in the 
change in hepatic distribution of methyl label into PC (~38%) versus creatine (~48%). 
This suggests GAA supplementation led to higher creatine synthesis which was 
facilitated at the expense of PC synthesis. Limited PC synthesis may lead to reduce 
VLDL secretion by hepatocytes, rsulting in hepatic triacylglycerol accumulation.  
 We also observed a 2 fold higher concentration of plasma GAA in the Excess 
Arg/Met group compared to the GAA/Excess Met group, but no difference in hepatic 
GAA. This suggests dietary GAA is immediately utilized by liver to synthesize 
creatine, as has been previously demonstrated in rats (Da Silva et al., 2009); but in 
contrast to that study in rats, dietary GAA did not reach the post-hepatic circulation in 
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our piglets, perhaps because our dietary level was supplemented at a rate that was 
efficiently metabolized by the liver. In neonatal piglets, ~20-30% of dietary 
methionine is used by the gut including protein, transmethylation and transsulfuration 
reactions (Shoveller et al., 2003b; Riedijk et al., 2007). However, most of the 
remaining methionine is distributed in the body with a substantial proportion 
sequestered by the liver. Endogenous GAA is thought to be mainly synthesized in the 
kidney from arginine and exported to the blood for circulation to the liver via the renal 
vein and the caudal vena cava (Edison et al., 2007). So higher plasma GAA 
concentrations in the Excess Arg/Met group are likely due to the fact that samples 
were taken from the ‘post-renal’ caudal vena cava where circulating GAA is higher, 
compared to the dietary GAA groups where little GAA appears in the post-hepatic 
vena cava. 
 Supplementing excess methionine did not change the fractional synthetic rate 
of hepatic protein compared to the deficient methionine diets, but it did change 
transmethylation rates. This suggests that a similar amount of dietary methionine is 
partitioned to hepatic protein synthesis, even when marginally deficient. Therefore, 
we might conclude that hepatic protein synthesis is conserved at the expense of 
transmethylation, when methionine is limiting. The hepatic protein synthesis result is 
in agreement with the work of Bauchart-Thevret and coworkers, who suggested that 
hepatic protein synthesis is preserved over methionine transmethylation in neonatal 
piglets when fed a methionine/cysteine free diet (Bauchart-Thevret et al., 2009). If we 
use hepatic protein synthesis as a biomarker of methionine deficiency, then it could be 
argued that the Base diet was not ‘deficient’ in methionine. However, if 
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transmethylation was used as a marker, then methionine was deficient since PC 
synthesis via PEMT did respond to dietary methionine. 
 Hepatic protein turnover is higher than muscle protein turnover (Millward & 
Garlick, 1972) in rapidly growing piglets. We observed higher hepatic protein 
turnover than muscle protein turnover only in Excess Met/Arg and GAA/Excess Met 
groups. Unexpectedly, the deficient methionine diets increased the fractional synthetic 
rate of the muscle protein compared to the excess methionine diets. The reason why a 
deficient methionine diet results in more muscle protein remains unexplained, but this 
was a consistent observation that was verified by a separate study conducted in our lab 
using the same diets.   
 As the precursor for homocysteine, high dietary methionine generally induces 
hyperhomocysteinemia in rats (Stead et al., 2001; Fukada et al., 2006a). GAA-
induced hyperhomocysteinemia has also been observed in rats (Stead et al., 2001; 
Fukada et al., 2006a) and in humans (Ostojic et al., 2013). Interestingly, no difference 
was observed in plasma or hepatic homocysteine concentrations in GAA/Excess Met 
group compared to other groups. This may be due to interspecies differences or 
because GAA-induced hyperhomocysteinemia can be overcome by providing excess 
methionine. However, hepatic taurine concentration was higher in excess methionine 
groups compared to deficient methionine groups. Taurine is synthesized from 
cysteine, which is the only precursor for taurine synthesis and a limiting amino acid 
for glutathione synthesis (Tappaz, 2004). Higher hepatic and plasma taurine 
concentrations indicate that the transsulfuration pathway is more active when excess 
methionine is supplemented, which was expected. SAM is known as the allosteric 
activator of CBS (Prudova et al., 2006; Riedijk et al., 2007), the rate limiting enzyme 
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in the transsulfuration pathway (Riedijk et al., 2007). Although I did not measure CBS 
activity, a higher SAM concentration in the excess methionine groups may have led to 
up-regulated CBS activity thereby facilitating transsulfuration. Also, lower 
homocysteine concentrations in plasma in the Excess Arg/Met group compared to the 
Base group may also be due to the activation of CBS by SAM. Moreover, methionine-
induced hyperhomocysteinemia can be suppressed by serine and glycine as reported in 
rats (Fukada et al., 2006b). Serine is a substrate for CBS enzyme. A lower hepatic 
serine concentration in the GAA/Excess Met group may suggest that serine was 
utilized by CBS in this group. Overall, these hepatic metabolite concentrations suggest 
that methionine deficiency leads to reduced hepatic and plasma taurine and reduced 
available methyl groups for SAM dependent methylation.   
4.5. Arginine metabolism in neonatal piglets 
 In contrast to plasma, where arginine concentrations were higher with arginine 
supplementation, hepatic arginine concentrations did not change with deficient or 
excess arginine in diets. However, the hepatic ornithine concentrations were higher 
with excess arginine supplementation. This suggests that arginine entering the liver is 
disposed immediately via urea synthesis, similar to how hepatic methionine seems to 
be rapidly converted to SAM with supplemental methionine. The excess arginine 
supplementation also led to lower hepatic glycine. Because the arginine amidino 
group is transferred to glycine to produce GAA, these data are consistent with the 
significantly higher GAA and lower glycine in plasma in these groups, compared to 
arginine-deficient groups. Also, excess arginine led to lower serine concentrations 
which may be due to higher glycine synthesis from serine (Schlupen et al., 2003). 
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 Glutamine synthesis is the alternative pathway for ammonia disposal when 
arginine is deficient in the diet. Rapid increases in glutamine concentrations are 
observed in enterally fed neonatal piglets with no arginine in their diet (Brunton et al., 
1999). When arginine is limited in the diet, urea synthesis is hampered and resulting 
ammonia is removed by the glutamate/glutamine mechanism. This may lead to 
significantly higher hepatic glutamine concentrations, as observed in pigs on the low 
arginine diets compared to the excess arginine group. This also validates our model 
that presumes a dietary arginine intake at 0.3 g/kg/day is marginally deficient in 
neonatal piglets. Moreover, plasma GAA concentrations were also significantly lower 
in arginine deficient animals compared to animals with excess dietary arginine, which 
suggests that GAA synthesis is reduced when arginine is deficient. 
 In summary, supplementing creatine led to higher hepatic and plasma creatine 
concentrations but did not increase muscle creatine. It also led to a reduction of the 
fractional synthetic rate of creatine in the liver. For the other groups, higher hepatic 
and plasma creatine concentrations were observed only when the supply of methyl 
groups was expanded in the diet. The fractional synthetic rate of hepatic protein was 
not affected by supplementation with GAA and creatine, demonstrating that hepatic 
protein synthesis was conserved over transmethylation reactions when methionine was 
limiting. 
5. Conclusion and future directions 
Amino acids are expensive and half of the feed costs to domestic animal 
producers are comprised of amino acids and proteins. Therefore, feeding precursors or 
products of these amino acids could potentially reduce the cost of the production. In 
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this present study, we intended to measure the sparing effect of creatine and GAA on 
methionine and arginine.  
In piglets, GAA supplementation is effective at increasing creatine stores, but 
only when methionine is excess, and at the expense of PC synthesis, but not hepatic 
protein. However, GAA supplementation does not seem to spare arginine for growth. 
We conclude that the demand for methionine should be considered when GAA is 
added to the diet so that methyl groups are not potentially limited. Another potential 
strategy is to provide excess remethylation precursors (ie betaine, choline, folate, 
serine) which could increase methionine availability by facilitating enhanced 
remethylation from homocysteine to methionine. 
Creatine supplementation is effective, but not as effective as GAA, at 
increasing creatine stores, but it does not seem to spare methionine or arginine for 
growth and/or protein synthesis, in spite of feeding creatine and GAA well in excess 
of normal intakes from sow's milk. We fed creatine and GAA at levels that would 
have replaced any need for de novo synthesis of these metabolites, so methionine and 
arginine should have been spared from those pathways.  At this time, the metabolic 
consequences of creatine supplementation on methionine metabolism remain 
unknown, especially on transmethylation flux. The lower PC synthesis has several 
implications for neonatal pigs. Although PC can be synthesized from preformed 
choline, PEMT-derived PC contains higher amounts of essential long chain fatty acids 
than PC synthesized from choline. Also, the sparing effects of dietary creatine and 
GAA on methionine and arginine for muscle protein synthesis and/or growth remain 
unknown in piglets. Therefore, future studies should investigate the effect of excess 
creatine supplementation on methionine interchange between transmethylation and 
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protein synthesis when methionine is excess in diet. Also, the effect of excess GAA 
supplementation on arginine interchange between protein synthesis and other 
metabolic pathways when arginine is excess in the diet needs to be investigated. 
Further studies are warranted in the field to observe the sparing effect of the above 
amino acids for protein synthesis and/or growth by simply measuring the growth rate 
and nitrogen balance. Because protein synthesis is easier to measure than protein 
breakdown, it is easy to misinterpret protein synthesis as protein balance. But if 
breakdown decreases proportionate to synthesis, then there is no net balance change. 
So a more complete investigation of protein balance is warranted before making 
assumptions about protein synthesis data. 
The piglet amino acid requirement data are transferrable to the human infant 
after adjustments are made for the rapid growth rate of the piglets. Some of the 
commercial infant formulas (ie soy) are virtually creatine-free, while cow-milk-based 
formulas vary in creatine content. Therefore, supplemental arginine and methionine 
could be considered in such formulas to accommodate the potentially higher amino 
acid requirements for added creatine synthesis.  
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Appendices 
Appendix I: Amino acid profiles of adaptation diet and experimental diet 
 
 
 
 
 
 
 
 
 
 
 
 
* Glycine-Tyrosine dipeptide 
** Creatine monohydrate    
Amino acids 
Adaptation diet Base Base+GAA Base+CRE Excess Arg/Met GAA/Excess Met 
g/kg/day g/l g/kg/day g/l g/kg/day g/l g/kg/day g/l g/kg/day g/l g/kg/day g/l 
Alanine 1.45 5.89 3.04 11.16 2.82 10.39 2.82 10.38 0.00 0.00 2.61 9.61 
Arginine 0.94 3.65 0.30 1.10 0.30 1.10 0.30 1.10 1.80 6.62 0.30 1.10 
Aspartate 0.94 3.32 0.94 3.47 0.94 3.47 0.94 3.47 0.63 2.31 0.94 3.47 
Cysteine 0.22 0.76 0.22 0.83 0.22 0.83 0.22 0.83 0.22 0.83 0.22 0.83 
Glutamate 1.63 5.72 1.63 6.00 1.63 6.00 1.63 6.00 1.63 6.00 1.63 6.00 
Glycine 0.48 1.47 0.36 1.31 0.36 1.31 0.36 1.31 0.36 1.31 0.36 1.31 
Histidine 0.48 1.69 0.48 1.76 0.48 1.76 0.48 1.76 0.48 1.76 0.48 1.76 
Isoleucine 0.72 2.51 0.72 2.64 0.72 2.64 0.72 2.64 0.72 2.64 0.72 2.64 
Leucine 1.62 5.67 1.62 5.94 1.62 5.94 1.62 5.94 1.62 5.94 1.62 5.94 
Lysine-HCl 1.10 5.58 1.29 5.91 1.29 5.91 1.29 5.91 1.29 5.91 1.29 5.91 
Methionine 0.30 1.04 0.20 0.74 0.20 0.74 0.20 0.74 0.50 1.84 0.50 1.84 
Phenylalanine 0.82 3.00 0.61 2.24 0.61 2.24 0.61 2.24 0.61 2.24 0.61 2.24 
Proline 1.29 4.52 1.29 4.73 1.29 4.73 1.29 4.73 1.29 4.73 1.29 4.73 
Serine 0.87 3.11 0.87 3.19 0.87 3.19 0.87 3.19 0.87 3.19 0.87 3.19 
Taurine 0.07 0.27 0.07 0.28 0.07 0.28 0.07 0.28 0.07 0.28 0.07 0.28 
Tryptophan 0.33 1.14 0.33 1.21 0.33 1.21 0.33 1.21 0.33 1.21 0.33 1.21 
Tyrosine 0.12 0.44 0.12 0.43 0.12 0.43 0.12 0.43 0.12 0.43 0.12 0.43 
Valine 0.82 2.89 0.82 3.03 0.82 3.03 0.82 3.03 0.82 3.03 0.82 3.03 
Threonine 0.82 2.23 0.82 3.03 0.82 3.03 0.82 3.03 0.82 3.03 0.82 3.03 
GT* 0.00 0.00 0.38 1.63 0.38 1.63 0.38 1.63 0.38 1.63 0.38 1.63 
Creatine 
(CMH**) 
 
0.00 
 
0.00 0.00 0.00 0.00 0.00 0.12 0.44 0.00 0.00 0.00 0.00 
GAA 0.00 0.00 0.00 0.00 0.09 0.34 0.00 0.00 0.00 0.00 0.09 0.34 
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Appendix II: D-glucose and major minerals concentrations in the diets 
  
 
 
 
 
 
 
 
Appendix III: Trace mineral concentrations in the diets 
 
 
 
 
 
 
  
Composition g/l of diet 
D-glucose 90.3 
Trihydrate K2HPO4 1.57 
Monobasic KH2PO4 1.09 
Potassium acetate 1.47 
MgCl 2.17 
MgSO4 0.78 
Calcium gluconate 6.41 
Elements Minerals supplied  mg/kg of BW/day g/l of diet 
Zine ZnSO4.7H2O 10.09 40.78 
Copper CuSO4.5H2O 0.86 3.12 
Manganese MnSO4.H2O 0.66 1.89 
Chromium CrCl3.6H2O 0.01 0.05 
Selenium SeO2 0.05 0.06 
Iodine NaI 0.02 0.02 
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Appendix IV: Commercial multi-vitamin mix composition 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inactive ingredients in vial 1: 50 mg polysorbate 80, sodium hydroxide and/or 
hydrochloric acid for pH adjustment. 
Inactive ingredient in vial 2: 75 mg mannitol, citric acid and/or sodium citrate for pH 
adjustment  
Vial 2 was mixed with vial 1 just prior to use. 3 ml of the mixed solution was added to 
each 750 ml diet bag, to deliver the vitamin dose. 
 
Vitamins Each 4 ml of vial 1 
contains 
Dose (per kg of 
BW/day) 
Ascorbic acid 
 (vitamin C) 
80 mg 17.41 
Vitamin A  (as palmitate) 2300 IU 500.48 
Vitamin D3 (cholecalciferol) 400 IU 87.04 
Thiamine (Vitamin B1) (as 
the hydrochloride) 
1.2 mg 0.26 
Riboflavin (Vitamin B2) (as 
riboflavin-5-phosphate 
sodium) 
1.4 mg 0.30 
Pyridoxine HCl (Vitamin 
B6) 
1 mg 0.22 
Niacinamide 17 mg 3.70 
Dexpanthenol (as d-
pantathenyl alcohol) 
5 mg 1.1 
Vitamin E (dl-α-tocopheryl 
acetate) 
7 IU 1.52 
Vitamin K1 0.2 mg 0.04 
 Each 1 ml of vial 2 
contains 
 
Folic acid 140 µg 4.35 
Biotin 20 µg 30.46 
Vitamin B12 
(cyanocobalamin) 
1 µg 0.22 
